patient	303
premenopausal women	330
matched controls	217
commonly associated	184
type diabetes mellitus	691
clinical factors	281
kidney function	113
cross sectional study	657
population based cohort	109
negatively associated	508
positive association	336
weight gain	161
positively associated	1003
glycemic control	101
heterogeneous disease	268
secondary analysis	100
significant prognostic factors	142
survival curves	251
event free survival	355
independent predictors	797
overall survival	11628
nk cells	1684
functional studies	299
tumor marker	162
also show	362
often associated	429
immune surveillance	186
cell lymphomas	425
mycosis fungoides	245
metastatic melanoma	1081
widely used	1241
also expressed	264
diagnostic utility	198
pleural effusions	142
lymphoproliferative disorders	102
cytoplasmic expression	139
differential diagnosis	1757
cost effective	442
pancreatic neuroendocrine tumors	198
ki index	233
natural history	442
clinical behavior	202
previously described	331
world health organization	335
current study	2263
eus fna	140
results indicate	3800
alternative approach	110
patient prognosis	319
functional analyses	111
rare type	169
previous studies	2305
different subtypes	209
previous study	751
small interfering rna	725
growth inhibition	514
molecular mechanisms	2215
differentially expressed genes	837
analyzed using	614
downregulated genes	149
signaling pathways	1164
microarray analysis	436
apoptosis related genes	124
results show	1807
flow cytometry	5624
several studies	754
neoplastic cells	500
report two cases	102
tumor cells	7725
classical hodgkin lymphoma	151
tissue samples	815
malignant melanoma	627
increasing number	426
personalized medicine	302
treat patients	275
clinical application	729
highly effective	280
mm patients	489
new generation	112
targeted drugs	131
vitro study	267
bcl protein	147
well understood	948
transmission electron microscopy	385
results provide evidence	178
sgc cells	291
potential therapeutic strategy	319
gastric cancer cells	1555
metabolic syndrome	1054
determine whether	865
insulin resistance	2641
randomly assigned	861
homeostasis model assessment	206
p moreover	272
annexin a2	166
data suggest	3900
matrix metalloproteinase	1619
polyethylene glycol	152
early detection	1515
lung cancer	7715
clinical practice	1678
high sensitivity	487
protein expression	4216
clinicopathologic parameters	203
epidermal growth factor receptor	3150
tumor type	295
tumor location	554
lymph node metastasis	4542
potential biomarker	1082
extracellular vesicles	266
insulin signaling	117
aldehyde dehydrogenase	214
limited number	364
previously reported	1592
critical role	2967
cancer cell proliferation	398
aldh1 expression	107
invasive ability	286
anticancer drug	174
results indicated	2189
new strategy	351
human hepatocytes	119
toll like receptor	683
promoter activity	210
gene expression	3674
luciferase assay	355
real time polymerase chain reaction	627
underlying mechanisms	1887
aggressive tumor	107
reported previously	251
useful biomarker	307
early diagnosis	1438
enzyme linked immunosorbent assay	1297
higher sensitivity	173
diagnostic accuracy	783
acute promyelocytic leukemia	396
present study aimed	1794
clinical outcomes	1738
retrospectively analyzed	796
clinical features	1668
complete remission	722
multivariate analyses	1010
commonly observed	165
positive rates	210
independent risk factor	652
multivariate analysis	3617
study population	291
functional roles	296
chronic inflammation	751
major cause	810
various types	1524
highly expressed	3058
hematopoietic cells	241
play crucial roles	145
adaptive immune responses	165
recent studies	1971
also involved	418
biological functions	809
extensively studied	371
numerous studies	308
closely related	933
innate immune response	191
review describes	168
inflammatory diseases	465
inflammatory bowel disease	1018
inflammatory conditions	171
gastrointestinal tract	569
crohn's disease	800
ulcerative colitis	725
broad spectrum	382
tumour necrosis factor	520
toxicity profile	116
study evaluated	345
malignant glioma	212
adjuvant chemotherapy	1286
retrospectively reviewed	740
medical records	764
adverse events	1457
rheumatoid arthritis	1547
recently developed	108
ra patients	394
present review	303
generally well tolerated	166
low rate	120
still limited	159
promising treatment	110
combination therapy	1261
trans retinoic acid	377
tumor cell	141
particle size	178
mcf cells	1714
time dependent manner	1031
markedly increased	276
vivo efficacy	169
chronic myeloid leukemia	1028
combined effects	197
cellular processes	384
malignant transformation	1181
several types	1165
solid tumors	2294
main cause	321
hematopoietic stem cells	361
metastatic colorectal cancer	1125
past two decades	112
patient selection	228
first line chemotherapy	401
first line setting	173
maintenance therapy	335
androgen deprivation therapy	532
prostate cancer	10026
patient outcomes	235
first line treatment	1180
metastatic disease	1314
widespread use	134
review focuses	554
side effects	992
therapeutic approaches	265
androgen deprivation	117
prostate cancer patients	584
key regulator	774
present study	13928
thyroid cancer cells	204
cell proliferation	8079
cell survival	1242
also evaluated	793
mitogen activated protein kinase	687
p38 mapk	522
specific inhibitor	306
findings demonstrate	985
results suggest	7552
risk factors	2262
many cases	190
unknown origin	134
systemic disease	194
also included	118
retrospective chart review	166
two groups	3141
normal range	231
significant difference	3792
significantly lower	3536
p furthermore	321
p conclusions	1442
cancer cells	10684
targeted therapies	1436
cancer patients	2883
clinical benefits	111
acquired resistance	1392
genetic alterations	622
tumor cell growth	187
tumor microenvironment	2516
growth factors	789
multiple signaling pathways	106
normal cells	1260
target genes	1466
hnscc cells	227
c src	165
increased apoptosis	580
negative regulator	663
p stat3	299
observations indicate	102
cardiovascular diseases	543
systematic review	2445
past decades	211
current guidelines	106
body weight	600
type diabetes	1545
healthy subjects	883
literature search	312
randomized controlled trials	407
beneficial effect	236
insulin sensitivity	360
inversely associated	528
inversely related	161
inverse association	215
ovarian cancer	5184
large number	873
areas covered	369
meta analyses	312
conflicting results	102
blood pressure	431
hypothalamic pituitary adrenal axis	188
frequently associated	314
cervical cancer	3584
rare cause	126
year old woman	1391
magnetic resonance imaging	1126
first report	851
high degree	367
breast cancer cells	4688
induce apoptosis	1257
cancer therapeutics	271
cytotoxic effect	638
drug resistance	2841
anti cancer effect	206
study investigates	181
results showed	4638
cleaved caspase	507
study demonstrates	1036
first time	3466
major role	779
tissue factor	184
blood vessels	368
decreased expression	1343
endothelial cells	1718
increased expression	2715
current evidence	158
epithelial cell adhesion molecule	213
favorable prognosis	457
platinum based chemotherapy	534
binding site	257
targeted therapy	1838
prognostic marker	1046
potential prognostic marker	227
epithelial ovarian cancer	1097
clinical data	1242
median age	2308
patients presented	254
significantly associated	7760
independent prognostic marker	369
data indicate	1593
significant association	2306
eoc patients	210
metastatic setting	156
locally advanced cervical cancer	109
endometrial cancer	1565
obese patients	248
breast cancer	19687
long term effects	131
neoadjuvant setting	129
pathologic complete response	245
clinical use	754
prostate health index	107
prostate specific antigen	1505
clinical suspicion	109
prostate biopsy	242
systematic search	191
time period	125
preferentially expressed	104
significantly elevated	765
aggressive disease	372
new biomarkers	177
significantly increase	109
clinical utility	674
study aimed	3635
digital rectal examination	174
demographic characteristics	163
mean age	2071
significant effect	548
various human cancers	295
bladder cancer	2569
results overall	435
univariate analysis	1237
performance status	541
diabetes mellitus	701
serum albumin	221
c reactive protein	1589
hazard ratio	3383
confidence interval	5085
transforming growth factor	1177
dual role	249
bladder cancer cells	570
cell lines	5916
mechanism involved	100
significant differences	2680
cell cycle	4787
apoptotic cells	563
cell line	802
high risk	2432
range years	313
bone marrow	1772
stem cells	923
peripheral blood	2311
median follow	3030
first complete remission	136
initial diagnosis	586
primary hyperparathyroidism	305
parathyroid adenoma	117
clinical diagnosis	475
genetic testing	581
successfully used	166
prognostic value	4304
disease progression	2594
healthy donors	716
roc curve	433
times higher	163
independent prognostic factor	2207
myeloproliferative neoplasms	499
frequently observed	519
case report	3419
gastric cancer	8749
human epidermal growth factor	109
unusual case	228
successful treatment	394
month history	128
adrenal gland	120
smooth muscle actin	436
anaplastic lymphoma kinase	727
successfully treated	281
first reported case	211
molecular targeted therapy	167
radiation exposure	133
peripheral blood lymphocytes	128
surrogate marker	228
methods patients	1577
blood samples	1103
results data	129
data show	761
first study	575
genetic aberrations	112
androgen receptor	1374
castration resistant prostate cancer	885
patients treated	2897
function mutations	506
polycystic ovary syndrome	1619
anti m√ºllerian hormone	164
newly diagnosed	321
university hospital	177
amh levels	109
significantly correlated	2540
body mass index	1857
new target	337
recently identified	351
active form	150
wide range	1315
role played	123
cancer progression	2434
prostate adenocarcinoma	144
united states	1064
prostate cancer risk	262
molecular mechanisms involved	226
tumor progression	3655
human prostate cancer	260
high frequency	604
previously identified	271
cancer types	522
hedgehog pathway	101
low levels	856
also observed	1725
ectopic overexpression	162
growth arrest	219
hh signaling	108
tongue squamous cell carcinoma	177
several malignancies	223
real time quantitative pcr	341
results using	134
high level	1009
tumor tissues	1940
results demonstrated	1933
nodal status	256
traditional chinese medicine	315
cyclin dependent kinase	537
molecular dynamics	161
colon cancer cells	1201
anti inflammatory properties	235
anticancer activity	947
lead compound	111
cell death	2549
thus suggesting	175
cells treated	709
comparative analysis	339
inflammatory factors	241
functional properties	135
malignant mesothelioma	233
antitumor immunity	205
three groups	955
healthy volunteers	815
granzyme b	221
study aims	1317
anticancer effects	625
inhibitory effects	1123
mtt assay	2229
combination index	114
reactive oxygen species	2450
mitochondrial membrane potential	1165
synergistic effect	660
cell cycle arrest	2031
ros production	333
apoptosis induction	679
polycystic ovarian syndrome	264
prospective study	841
healthy women	331
four groups	331
national institute	128
homa ir	695
chinese patients	700
esophageal squamous cell carcinoma	1717
frequently overexpressed	266
escc patients	451
colony formation	1878
anchorage independent growth	399
soft agar	188
nude mice	1676
may serve	864
potential therapeutic target	2334
underlying molecular mechanisms	579
high expression	3282
independent predictor	1363
vitro assays	265
studies demonstrated	126
data reveal	309
previous study demonstrated	122
protein levels	3247
significantly decreased	1862
c myc	2026
literature review	1006
autoimmune disorders	182
patient died	166
high mortality rate	239
cancer cell survival	158
drug response	175
prostate cancer cells	1627
pc3 cells	410
significant decrease	1133
promising biomarker	274
tumor response	480
living cells	243
induces apoptosis	996
underlying mechanism	1601
western blot analysis	2753
p jnk	141
concentration dependent manner	711
significantly upregulated	1119
chemotherapeutic drugs	506
synergistic effects	309
central role	977
immune responses	557
il il	799
immunohistochemical study	372
soft tissues	110
microvessel density	482
tumor grade	925
possibly due	164
breast cancers	1296
monoclonal antibody	510
breast cancer patients	3131
prognostic biomarker	789
poor overall survival	723
clinical trials	3101
biological role	461
tumor initiation	444
advanced disease	602
inhibit tumor growth	153
recent study	146
results demonstrate	2073
autophagy inhibition	136
common feature	259
many cancer cells	100
provide evidence	688
glucose metabolism	525
different levels	261
one hand	173
pentose phosphate pathway	124
reduced levels	254
increased resistance	122
malignant phenotype	409
melanoma patients	502
gene expression profiles	443
immunohistochemical analysis	1133
human cells	526
metastatic phenotype	105
extracellular matrix	1206
mechanism underlying	456
taken together	5998
brain metastasis	502
natural killer cells	324
minimal residual disease	371
natural killer	777
increased significantly	232
gastric cancer cell lines	251
first affiliated hospital	128
xenograft tumors	275
quantitative polymerase chain reaction	431
increased levels	931
advanced tumor stage	250
opposite effects	304
parp inhibitors	532
poly(adp ribose	493
vital role	510
docking studies	113
active site	299
see text	289
year survival	346
last decade	519
primary treatment	232
targeted agents	379
poor prognosis	9177
molecular profile	159
differential expression	779
cell adhesion molecules	115
possible role	738
biological behavior	393
different types	1137
highest expression	101
possible association	353
squamous cell carcinoma	2087
late diagnosis	108
normal mucosa	228
clear cell renal cell carcinoma	871
hypoxia inducible factor	965
constitutively expressed	109
transgenic mice	146
tissue microarray	611
hif expression	293
elevated expression	622
renal cell carcinomas	120
immunohistochemical expression	638
important role	8233
embryonic development	464
reduced expression	922
study indicates	436
braf mutations	547
molecular analysis	444
also associated	1116
braf v600e	245
positive cases	112
dna pkcs	193
predictive markers	233
therapeutic resistance	344
decreased survival	170
study suggested	340
tumor suppressors	557
transcription factor	890
thyroid tumors	106
comparative study	304
colon adenocarcinoma	112
staining intensity	205
statistical analysis	912
p values	274
statistically significant	1769
statistically significant differences	526
significantly higher	8366
larger sample size	116
breast tumors	489
estrogen receptor	2302
progesterone receptor	1284
epithelial membrane antigen	236
tissue sections	161
multiple myeloma cells	216
multiple myeloma	2550
myeloma cells	248
mm cells	476
expression levels	6186
apoptosis induced	485
study showed	865
mm cell lines	117
human cancers	2226
adverse outcome	114
quantitative pcr	386
mir 5p	3005
inversely correlated	1206
ectopic expression	1469
mir 3p	2159
induced apoptosis	1647
survivin expression	222
decreased cell proliferation	127
tumor suppressive function	114
promising therapeutic strategy	309
nuclear factor Œ∫b	618
important risk factor	135
fully elucidated	831
apoptotic cell death	400
activator protein	101
nf Œ∫b	3484
lipid peroxidation	231
extracellular signal regulated kinase	600
common mechanism	114
whereas inhibition	129
core needle biopsy	127
critically involved	144
cancer treatment	1938
previously found	213
inhibitory effect	1719
non small cell lung cancer	6461
cell viability assay	137
nsclc cells	1360
cyclin e1	119
mammalian target	1427
cell growth	2217
anti tumor effects	308
epigenetic modification	114
standard treatment	533
increasing evidence suggests	134
including proliferation	135
specific genes	113
conclusions although	238
exact role	252
pathological conditions	356
matrix metalloproteinases	729
also tested	175
ic50 values	620
several diseases	180
neurodegenerative disorders	192
molecular imaging	201
cancer detection	143
accurate diagnosis	294
cytotoxic agents	189
therapeutic management	109
clinical course	609
immunosuppressive therapy	142
curative treatment	163
standard therapy	334
second line	180
future research	314
treatment response	792
cell lymphoma	1395
increased incidence	341
high levels	1988
identified patients	351
potential confounders	199
future studies	770
anaplastic large cell lymphoma	198
ct scan	186
skin lesions	213
heart failure	469
cause mortality	545
interquartile range	521
age years	686
female gender	158
improved outcomes	163
many types	754
newly diagnosed glioblastoma	103
survival benefit	478
progression free survival	3405
significantly increased	2953
proteasome inhibitor	118
human pancreatic cancer cells	169
pancreatic cancer cells	1144
tumor targeting	105
cellular uptake	483
growth inhibitory effects	115
targeted delivery	326
anticancer drugs	615
oncogenic role	578
renal cell carcinoma	1992
tumor stage	1044
cancer specific survival	491
multivariate cox regression analysis	204
multivariate analysis revealed	467
novel therapy	111
dendritic cells	924
cell immunity	160
cell activation	615
tnf production	127
monoclonal antibodies	759
novel role	520
adaptive immunity	228
benign prostatic hyperplasia	322
disease severity	351
multivariate logistic regression	120
older patients	521
clinical significance	3754
surgical resection	1211
gastric cancer patients	988
results reveal	538
different populations	107
gallbladder cancer	317
common malignancy	338
urgently needed	599
amp activated protein kinase	304
co treatment	490
fluorouracil fu	465
ampk activation	124
gene expression profiling	435
gastrointestinal stromal tumors	384
dna methylation	1585
important mechanism	208
cancer related genes	215
clinicopathological parameters	1026
clinical follow	226
shorter disease free survival	156
tumor size	3236
epigenetic regulation	534
functional impact	113
vivo study	129
gold nanoparticles	200
cell cultures	111
nervous system	248
blood brain barrier	417
c57bl/6 mice	140
electron microscopy	254
findings provide	519
molecular mechanism	1650
anticancer effect	475
study evaluates	109
cytotoxic effects	794
dose dependent manner	2352
flow cytometry analysis	399
mda mb cells	1393
caspase caspase	172
human breast cancer cell lines	153
findings suggest	4439
transcriptional repression	138
c jun	386
diabetic nephropathy	147
play key roles	169
regulatory mechanism	320
side population	105
normal control group	135
sp cells	150
cck assay	499
blank control group	167
g2/m phase	686
p p	226
g0/g1 phase	705
statistical difference	264
also increased	314
cutaneous squamous cell carcinoma	246
activating transcription factor	162
cancer biology	451
serum starvation	112
potential diagnostic	199
human gliomas	174
common type	636
patients diagnosed	1236
regulated genes	285
western blot	4595
strongly associated	988
high grade glioma	173
strongly correlated	329
patient outcome	339
poor outcome	933
nasopharyngeal carcinoma cells	122
subcellular localization	397
cytochrome c	629
endoplasmic reticulum	883
pro inflammatory cytokines	695
nasopharyngeal carcinoma	1270
abiraterone acetate	190
metastatic castration resistant prostate cancer	584
biological significance	295
pc cells	665
expression profile	546
positive staining	211
positive expression	538
higher frequency	327
computed tomography	906
mean follow	625
exon deletion	132
clinical phenotype	139
one third	356
therapeutic implications	329
better understanding	1368
molecular data	112
pathological features	409
genetic features	149
grade iii	264
pik3ca mutations	372
spinal cord	337
cox expression	378
mir 146a	436
lung cancer cells	1558
arachidonic acid	137
numerous cancers	138
including lung cancer	107
regulate gene expression	196
human cancer	1169
higher levels	1058
mrna expression	1798
biological activity	441
prospective cohort study	248
general population	996
increased risk	4840
younger age	404
genetic predisposition	203
informed consent	124
primary endpoint	1127
young women	322
background breast cancer	218
aggressive phenotype	342
worse prognosis	760
years old	661
statistically analyzed	220
qrt pcr	3165
p value	526
cell motility	499
study suggests	1172
clinical setting	511
mir 125a	102
clinicopathological features	2083
situ hybridization	2387
adjacent normal tissues	1097
negatively correlated	1426
independent factors	168
mir expression	1735
breast cancer tissues	502
adjacent tissues	442
positively correlated	2586
breast cancer development	244
allogeneic hematopoietic stem cell transplantation	304
early childhood	104
highly variable	159
clinical characteristics	1618
skin rash	101
gm csf	510
genetic analysis	259
e cadherin	3276
oral squamous cell carcinoma	1617
surgical treatment	582
lymph node metastases	713
vimentin expression	203
tumor cell proliferation	347
tumor angiogenesis	726
preclinical models	554
also correlated	202
potential biomarkers	677
bcl xl	791
co administration	217
open label	683
time points	260
half life	210
safety profile	308
partly due	117
differentiated thyroid cancer	277
primary tumours	197
high density	120
anticancer therapy	317
data regarding	100
normal group	153
hyaluronic acid	218
significant correlation	1448
negative correlation	656
patient groups	137
prognostic impact	883
ccrcc patients	195
tp53 mutations	480
tumour stage	122
independent prognostic biomarker	127
chromosomal instability	198
thyroid nodules	344
point mutations	276
somatic mutations	1000
targeted next generation sequencing	170
colorectal cancer	9427
disease stage	319
significantly improved	355
epithelial mesenchymal transition	3287
data demonstrate	991
increased numbers	142
parathyroid hormone	238
still unknown	630
immunohistochemical staining	1710
directly correlated	132
mrna levels	1295
recently shown	320
cancer initiation	275
adrenocortical carcinoma	175
thyroid cancer	1171
normal tissue	631
benign tumors	278
inverse correlation	503
first line therapy	647
patients affected	292
follicular lymphoma	468
novel approaches	129
overall response rate	653
two patients	1076
stable disease	797
median overall survival	1119
year os rate	120
partial responses	157
single nucleotide polymorphisms	1106
promoter region	756
tumour necrosis factor alpha	220
determined using	546
control group	5906
allele frequency	132
g allele	312
significant associations	521
control groups	907
photodynamic therapy	450
hpv dna	212
recurrence rate	281
detection rate	245
medullary thyroid carcinoma	268
meta analysis	7148
patient age	374
poorer prognosis	519
fine needle aspiration cytology	138
published data	195
diagnostic performance	482
included studies	292
barrett's esophagus	285
pooled analysis	280
alcohol consumption	335
smoking status	533
cigarette smoking	229
esophageal adenocarcinoma	364
toll like receptors	303
wild type	1493
endothelial dysfunction	228
plasma samples	458
peripheral blood mononuclear cells	864
wt mice	153
p akt	910
lc3 ii	276
upstream regulator	100
pi3k/akt pathway	564
significantly inhibited	638
human cancer cells	518
receptor activator	280
nuclear factor kappa b	473
bone resorption	144
chronic inflammatory diseases	100
potential therapy	109
malignant cells	703
arsenic trioxide	331
transwell assays	545
mechanisms involved	369
luciferase reporter assays	281
distant metastasis	1899
cancer metastasis	694
cxcr4 expression	182
cervical carcinogenesis	152
closely associated	1042
cervical cancer patients	288
anti cancer agents	125
cancer therapy	2728
gastric adenocarcinoma	519
underwent resection	145
primary aim	153
local recurrence	755
secondary endpoints	262
recurrence free survival	791
p compared	481
median os	887
n stage	291
worse os	239
treatment outcomes	388
disease free survival	2660
oscc patients	383
advanced stage	903
treatment outcome	364
nodal metastasis	250
brca mutation carriers	140
brca mutations	175
tumor characteristics	409
lymphovascular invasion	624
human epidermal growth factor receptor	1512
brca mutation	123
poorly differentiated tumors	115
identifying patients	207
hereditary breast	217
disease control	235
public health	103
medical history	140
family history	1262
brca2 mutation	110
uncertain significance	107
genomic profiling	131
routine clinical practice	194
drug administration	585
clinical relevance	951
clinicopathologic characteristics	467
retrospective cohort study	448
chi square test	434
patients presenting	288
malignant potential	255
therapeutic target	2404
mir overexpression	383
gastric cancers	253
mir cluster	235
prognostic significance	2873
epstein barr virus	680
clinicopathological significance	521
b symptoms	112
poor prognostic factors	114
low risk	724
intermediate risk	218
low risk group	162
year os	484
high risk group	245
independent poor prognostic factor	157
year old man	1488
pulmonary adenocarcinoma	150
egfr mutation	648
treatment option	187
glutathione peroxidase	247
cancer risk	998
assess whether	179
oxidative stress	2735
energy metabolism	322
cancer res	366
cancer stem like cells	219
systemic treatment	274
attractive target	453
high specificity	282
tumor cell migration	118
glioblastoma multiforme	864
tumor recurrence	934
important part	130
cell types	536
major determinant	117
highly sensitive	440
b cells	1104
co culture	403
significant increases	163
cell type	267
first evidence	473
differentially regulated	122
hypothalamic pituitary adrenal	247
important regulator	389
stress response	255
healthy individuals	930
anti inflammatory effects	398
adverse effects	658
therapeutic approach	275
hpa axis	171
hepatocellular carcinoma	9451
advanced hcc	211
clinical benefit	552
tumor suppression	415
key mediator	191
hcc therapy	103
cancer screening	116
eligible patients	337
background lung cancer	119
non small cell lung cancers	214
oncogenic activity	140
cellular transformation	140
study identified	144
colony forming ability	118
stat3 signaling	173
li fraumeni syndrome	145
her2 status	560
lung adenocarcinoma	2228
gene mutations	388
her2 amplification	166
consecutive patients	736
also determined	355
five cases	239
nine cases	115
her2 expression	350
gene amplification	301
egfr mutations	1021
kras mutations	708
mutually exclusive	241
six cases	191
previously showed	287
rt pcr	2488
sirna knockdown	167
luciferase reporter assay	727
hcc patients	2232
significantly increased compared	188
hcc cell lines	604
hcc cells	2240
neoadjuvant chemotherapy	1437
following treatment	212
highly associated	236
er positive	273
residual disease	312
also identified	458
treatment groups	270
validation cohort	403
ihc staining	132
better understand	665
also demonstrated	557
glioma cells	1523
inducing apoptosis	833
locally advanced breast cancer	152
clinicopathological characteristics	1439
hormone receptor	321
triple negative breast cancer	2023
months ci	832
central nervous system	1250
common site	156
study suggest	324
major regulator	122
cell signaling	262
clinical role	108
still unclear	1039
methods one hundred	218
flight mass spectrometry	171
real time pcr	1797
also found	2402
advanced breast cancer	296
liver metastases	614
nuclear catenin	121
significant improvement	376
investigated using	180
cancer stem cell	272
significant increase	1737
study shows	669
cancer development	1690
human breast cancer cells	651
metastatic process	187
high concentrations	265
short term	186
immune response	1295
chronic hepatitis	143
liver cirrhosis	530
tumor necrosis factor alpha	1396
mice treated	247
crystal structures	148
specific binding	113
cystic fibrosis	121
cancer associated fibroblasts	469
malignant progression	489
cancer diagnosis	518
vivo models	324
molecular profiling	241
highly enriched	114
tumor stroma	313
acute pancreatitis	730
may contribute	924
cancer invasion	206
methods samples	102
cell cycle progression	1436
active role	113
gene transcription	254
human tumor cells	104
higher doses	111
cellular homeostasis	112
including cancer	461
predictive factor	192
therapeutic efficacy	815
factors associated	516
scanning electron microscopy	111
expression pattern	925
low expression	1398
promising target	628
biological evaluation	486
inhibitory activity	273
catalytic domain	126
mda mb breast cancer cells	276
significantly reduced	1399
lesser extent	220
shed light	287
balb/c mice	131
adp ribose	553
active caspase	117
breast cancer treatment	327
metastatic prostate cancer	401
tumor vasculature	170
fusion protein	171
crucial role	1811
genomic stability	183
potential target	1670
real time	220
anti tumor effect	351
phospho akt	137
phosphorylation level	159
c met	875
human lung cancer	247
several cancer cell lines	122
fluorescence microscopy	270
results also showed	114
western blot analysis revealed	212
hela cells	1254
systemic administration	161
vascular endothelial growth factor	2441
healthy tissues	145
thyroid gland	229
clinical studies	861
targeted inhibition	180
immunohistochemical profile	110
oral cavity	542
differ significantly	357
conclusions according	120
results obtained	381
biological properties	164
play critical roles	282
biological processes	461
mir family	291
still needed	136
vivo studies	423
anti tumor activity	426
clinical treatment	333
leukemia cells	571
u937 cells	194
also reduced	187
aml cells	432
cell cycle control	191
pancreatic ductal adenocarcinoma	1371
many cancers	909
microrna expression	221
pancreatic cancer	4286
nf Œ∫b pathways	117
frequently upregulated	118
nf Œ∫b pathway	459
ras mutations	204
years ago	119
immune system	1573
major histocompatibility complex	120
genomic dna	399
neck squamous cell carcinoma	1349
data showed	748
normal weight	139
coronary artery disease	246
poorly understood	1344
subcutaneous adipose tissue	166
genome wide association studies	344
odds ratio	2305
pathological processes	350
breast carcinogenesis	155
fully understood	1046
critical component	122
tumor formation	566
animal model	351
breast cancer cell lines	811
specific inhibitors	225
cyclin d1	2267
new mechanism	228
breast tumorigenesis	101
might benefit	106
programmed cell death	515
several mechanisms	123
wide spectrum	279
molecular alterations	260
ar v7	173
preclinical studies	404
drug development	371
mini review	109
new era	175
lifestyle factors	115
recently reported	546
sex hormone binding globulin	180
physical activity	440
elevated levels	682
current state	235
human breast cancer	683
current understanding	530
mtor pathway	365
therapeutic targeting	335
current literature	210
breast carcinoma	573
substantial proportion	123
false discovery rate	139
focal adhesion	156
metastatic potential	691
multiple cancer types	163
national cancer institute	172
mass spectrometry	598
methods expression	283
normal oral mucosa	106
tunel assay	231
western blotting	4597
cancer cell lines	913
results expression	215
study provides	681
ros generation	315
natural compounds	123
predictive factors	395
independently associated	1057
multivariate model	107
including hepatocellular carcinoma	134
hcc metastasis	136
significantly overexpressed	306
transforming growth factor beta	360
untranslated region	636
close relationship	139
cancer antigen	182
low cost	154
developed countries	223
molecular features	465
total number	422
mirna expression	397
average number	116
additional studies	280
predictive biomarker	429
receptor tyrosine kinases	344
recent years	1751
tumor suppressor gene	605
glioma tissues	369
protein expression levels	1187
multidrug resistance	815
also explored	186
bcl expression	309
ovarian cancer cells	1366
largely unknown	805
quantitative reverse transcription polymerase chain reaction	340
cell invasion	889
promoter methylation	603
control cells	737
aggressive behavior	338
non muscle invasive bladder cancer	156
prognostic factors	1596
recurrence rates	135
multivariable analysis	562
glioblastoma cells	582
basic fibroblast growth factor	171
signal transducer	903
mutant p53	390
wild type p53	210
sirna mediated knockdown	182
u251 cells	297
human glioma cells	240
cell migration	2687
cell metabolism	150
tumor therapy	143
cellular level	199
cellular localization	151
cell biology	115
lipid metabolism	505
protein kinases	135
transcription factors	1207
cellular responses	180
death receptors	126
combination therapies	217
serum level	479
clinical study	203
effective treatment	819
basal cell carcinoma	431
il interleukin	188
mantle cell lymphoma	485
retrospective study	1705
prognostic role	905
little information	131
proliferative activity	192
long term follow	609
positive correlation	1233
long time	156
mechanisms underlying	663
coding region	124
patient survival	997
new biomarker	147
plays important roles	266
emt process	304
mrna expression levels	559
mir 200a	207
cell cell adhesion	121
low grade	353
first year	288
transurethral resection	191
adjuvant treatment	454
relapse free survival	396
survival analysis	689
kaplan meier method	1309
results patients	709
average age	337
relative risk	403
adjuvant therapy	732
mitomycin c	157
preliminary results	153
clinical manifestations	365
early stages	811
non invasive	130
clinical outcome	1919
braf mutation	576
disease prognosis	124
case series	407
health study	116
odds ratios	717
non alcoholic fatty liver disease	294
4e bp1	171
tumor heterogeneity	201
protein level	1313
p respectively	1307
higher grade	157
genetic basis	253
tumor metabolism	102
well established	753
therapeutic strategy	448
increased cancer risk	121
cytokine secretion	158
antigen presentation	170
direct role	110
disease states	132
primary tumor	1283
worse overall survival	330
ovarian carcinoma	339
prognostic implications	260
receiver operating characteristic	692
curve analysis	159
cox proportional hazards regression model	117
potential association	238
cutoff value	270
ovarian carcinomas	118
poor survival	1568
ovarian cancer patients	558
significant prognostic factor	204
elevated level	142
tnm stage	1565
statistically associated	122
data suggested	447
novel prognostic marker	179
promising strategy	664
chronic lymphocytic leukemia	1482
b cell receptor	173
b cell malignancies	355
different stages	527
kinase inhibitors	204
neoplastic transformation	197
pivotal role	1205
lymphoid malignancies	146
many tumors	250
hematologic malignancies	632
novel approach	487
small molecules	501
recent findings	294
clinical development	649
past decade	421
treatment options	616
adoptive transfer	221
chimeric antigen receptor	394
recent developments	159
bruton's tyrosine kinase	129
combined use	273
aryl hydrocarbon receptor	244
chromatin immunoprecipitation	413
fluorescence activated cell sorting	160
signaling pathway	1105
cellular proliferation	568
protein kinase	296
higher concentrations	213
inhibit proliferation	207
lower risk	526
weight loss	685
incidence rate	225
ci p	610
molecular changes	136
esophageal cancer patients	127
esophageal cancer	1309
first description	110
regional lymph nodes	149
lymph nodes	1018
reduced proliferation	138
patients suffering	376
progressive disease	570
molecular genetics	116
molecular mechanisms underlying	470
gene fusions	120
e cadherin expression	536
lymphocyte ratio	404
colorectal carcinoma	799
long term survival	596
significantly longer	394
significantly different	1597
phosphorylation levels	209
smmc cells	195
increased phosphorylation	152
liver diseases	210
energy homeostasis	138
enhanced expression	375
therapeutic benefit	180
updated meta analysis	141
eligible studies	350
control subjects	721
subgroup analyses	349
genetic models	182
overall population	192
results suggested	1472
increased susceptibility	266
childhood acute lymphoblastic leukemia	235
non coding rnas	342
untranslated regions	112
case control study	1164
healthy children	118
pcr rflp	422
cc genotype	402
decreased risk	545
larger studies	197
mitochondrial dysfunction	420
a549 cells	1867
tumor suppressor protein p53	100
findings reveal	461
dna damage	1947
stem cell transplantation	131
acute myeloid leukemia	3158
myelodysplastic syndrome	452
classified according	258
protective effect	789
results provide	493
tumor bearing mice	274
positron emission tomography	435
anti her2 therapy	118
pet imaging	155
room temperature	114
hepatic fibrosis	106
liver disease	308
still poorly understood	249
liver fibrosis	360
mechanistic studies revealed	144
enzyme activity	178
data indicated	479
probably due	172
protein kinase c	241
key role	2258
clinical importance	212
primary tumour	216
postoperative complications	488
per cent	200
better survival	281
colorectal cancer patients	688
crc patients	1493
rna seq data	102
genes associated	448
kaplan meier curves	202
log rank test	1195
prognostic potential	178
would benefit	115
viral load	126
hepatoma cells	423
play important roles	690
recent evidence suggests	186
epigenetic silencing	312
human tumors	562
hcc tissues	1018
direct target	1110
negatively regulated	323
post translational modifications	235
lung tumors	161
data support	545
important implications	385
cell polarity	126
ovarian clear cell carcinoma	119
master regulator	386
metastatic ability	108
human breast cancers	123
mt1 mmp	260
ductal carcinoma	405
invasive ductal carcinoma	426
previous studies showed	159
target cells	358
stromal cells	757
study identifies	127
chimeric antigen receptors	100
antitumor efficacy	313
therapeutic potential	1317
nkt cells	118
tumor site	372
results establish	113
new therapies	297
new agents	123
near future	339
genetic abnormalities	113
conclusions patients	373
may benefit	293
molecular characterization	339
clinical management	625
future perspectives	162
basal like	180
lower expression	427
hormone receptors	206
higher expression	776
hormone therapy	260
review discusses	243
hepatitis b	220
postmenopausal women	774
il tnf	143
liver cancer	1129
short stature	115
missense mutation	119
potential candidates	106
next generation sequencing	1061
regulatory effects	123
focal adhesion kinase	357
key roles	114
well known	903
multidisciplinary approach	138
focal adhesions	146
dna damage response	792
part due	169
human disease	304
mir expression level	103
cancer genome atlas	1283
review summarizes	444
ovarian hyperstimulation syndrome	150
essential role	1054
serum levels	1942
healthy controls	3833
tumor tissue	1313
systemic inflammatory response	127
leading cause	1447
cancer mortality	237
anticancer activities	215
studies suggest	271
colorectal cancer risk	209
dna repair	1069
exclusion criteria	225
random effects model	257
publication bias	404
crc risk	235
conclusions based	236
mean age years	354
concordance rate	125
nodal metastases	129
her2 positive	456
metastatic tumors	327
seven cases	153
her2 negative	261
four cases	300
significant correlations	271
bc patients	382
metastatic lymph nodes	237
targeted treatment	191
causal role	112
also important	126
high sensitivity c reactive protein	299
hs crp	398
tumor necrosis factor	3528
alanine aminotransferase	304
lipid profile	241
high density lipoprotein cholesterol	131
uric acid	107
egfr tkis	977
tyrosine kinase inhibitors	1143
egfr tki	512
better outcome	191
small molecule	179
cell acute lymphoblastic leukemia	361
effective therapies	265
glucocorticoid receptor	220
heat shock protein	523
cell responses	864
recently demonstrated	265
cell expansion	111
mouse model	1099
dual targeting	129
soft tissue sarcoma	176
cik cells	126
soft tissue sarcomas	203
major component	200
transcriptional activity	756
may provide	442
therapeutic intervention	580
novel strategies	127
long term efficacy	118
cell surface	810
high mobility group box	207
previous findings	128
new targets	142
transformed cells	194
soluble form	129
myeloid derived suppressor cells	442
tumor regression	190
tumor relapse	154
programmed cell death ligand	185
pd l1	2970
positive control	198
promising approach	440
proinflammatory cytokines	784
interleukin beta	126
cognitive function	148
second line treatment	419
patients received	311
molecular docking	315
cell nucleus	100
reproductive age	189
estrogen receptors	286
poor os	295
adjusted hr	119
poor prognostic factor	228
direct interaction	295
lc ms/ms	245
molecular basis	750
dna binding activity	103
escherichia coli	205
work provides	105
locoregional recurrence	166
survival outcomes	557
previously demonstrated	551
vitro models	219
mtt assays	219
systemic inflammation	461
inflammatory biomarkers	214
randomly allocated	144
il tumor necrosis factor	186
erythrocyte sedimentation rate	192
placebo group	506
serum concentrations	356
study groups	135
clinical symptoms	320
common cancer	555
superoxide dismutase	419
significantly enhanced	369
expression level	3234
novel biomarkers	297
human colorectal cancer	381
year survival rate	526
past years	399
markedly decreased	186
early event	167
positive regulator	191
pancreatic adenocarcinoma	379
breast cancer risk	1077
clinical applications	403
two cell lines	249
cell cycle analysis	383
proliferating cell nuclear antigen	252
high percentage	187
caco cells	286
hct116 cells	512
biological function	885
inhibited cell proliferation	168
glioma cell lines	204
novel therapeutic target	846
precursor lesions	128
microsatellite instability	559
msi h	252
study confirms	162
wnt signaling	549
histone deacetylase inhibitors	222
inducing cell cycle arrest	158
clinical effects	109
hematological malignancies	671
including cell proliferation	113
cell viability	3412
histone deacetylases	314
colorectal carcinomas	147
formalin fixed	590
paraffin embedded	223
higher risk	1454
poor outcomes	370
findings indicate	1841
han chinese population	116
functional effects	154
nf Œ∫b activity	175
il levels	559
bioinformatic analysis	207
peroxisome proliferator activated receptor	224
mononuclear cells	155
different concentrations	731
reverse transcription polymerase chain reaction	576
western blot assays	186
comprehensive search	122
potential involvement	144
lung carcinogenesis	104
various diseases	346
previous studies demonstrated	106
downstream targets	300
expression profiles	491
differentially expressed	1001
potential role	1922
lung cancer cell lines	257
mir may	255
solid cancers	204
may result	209
sonic hedgehog	246
also examined	534
significant inhibition	258
tumor growth	3716
tumor tissues compared	149
constitutively active	103
new therapeutic approach	108
antiproliferative activity	415
patient population	363
antiproliferative activities	101
pca cells	456
pi3k/akt signaling	153
human lung cancer cells	253
significant role	859
luciferase assays	207
muscle invasive bladder cancer	190
differentially expressed proteins	201
significantly altered	167
kyoto encyclopedia	334
candidate biomarkers	118
study confirmed	121
cancer tissue	229
hormonal therapy	228
surgical management	230
immune regulation	186
gold standard	441
brain tumors	458
high grade tumors	153
normal samples	211
normal controls	719
cross talk	425
study indicate	166
diagnostic value	852
circulating micrornas	135
also known	1516
receiver operating characteristic curves	169
fibroblast growth factor	400
promising biomarkers	146
signal transduction	454
various cell types	108
animal models	888
lung tissues	139
full length	105
osteosarcoma cells	875
numerous types	156
induce cell apoptosis	107
two drugs	165
combination treatment	673
proteins involved	403
results revealed	1260
cancer tissues	619
hepatic stellate cells	134
searched pubmed	154
cochrane central register	157
controlled trials	230
inclusion criteria	707
risk ratio	176
rr ci	577
active compounds	104
induce cell death	180
jurkat cells	278
mitochondrial pathway	299
diffuse large b cell lymphoma	1445
r chop	582
possible correlation	112
response rate	732
partial response	902
shorter progression free survival	115
poor clinical outcomes	207
multiple sclerosis	474
protein phosphatase 2a	190
genes involved	1200
direct binding	219
randomized controlled trial	320
limited due	157
potential mechanisms	388
therapeutic response	404
also showed	394
therapeutic effects	483
increasing concentrations	162
molecular events	100
tumor invasion	803
cll patients	361
high rates	227
improved survival	539
c x c motif	129
gene expression data	193
one hundred	247
three genes	212
large tumor size	217
diagnostic sensitivity	140
various tumors	342
plays critical roles	105
mrna level	585
significantly suppressed	308
study indicated	325
novel insight	134
il il il	211
significant predictor	399
acute lung injury	102
antitumor effects	655
human gastric cancer cells	243
present study suggest	199
inhibiting proliferation	129
significant effects	163
cellular differentiation	154
possible involvement	197
identify biomarkers	118
noncoding rnas	153
immunohistochemical findings	138
statistically significant difference	732
weakly positive	103
authors report	114
increasing age	134
fasting glucose	134
also assessed	466
waist circumference	377
hepatocellular carcinoma patients	179
various tissues	139
previous study showed	131
culture media	106
novel marker	146
inflammatory markers	730
serum creatinine	153
advanced clinical stage	281
case highlights	156
differential diagnoses	108
six patients	523
glucose transporter	191
p glycoprotein	728
gene therapy	431
much higher	340
physicochemical properties	118
inhibits apoptosis	117
prognostic factor	956
promoted cell apoptosis	178
similar effect	116
tumor promoter	165
myeloid malignancies	180
myelodysplastic syndromes	405
incompletely understood	187
hl cells	373
clinical response	627
significant reduction	1014
non responders	339
potential use	614
molecular markers	418
murine model	290
uveal melanoma	361
therapeutic options	333
study presents	116
possible target	100
cancer related deaths worldwide	196
therapeutic effect	543
study period	471
ic50 value	358
lung cancer susceptibility	136
google scholar	188
confidence intervals cis	130
lung cancer risk	486
cc vs	106
statistically significant association	246
dominant model	414
meta analysis suggests	150
malignant gliomas	228
wnt signaling pathway	450
recently found	162
colony formation ability	149
present study demonstrated	715
well characterized	381
remains unclear	646
gene regulation	239
molecular characteristics	324
alzheimer's disease	807
epigenetic modifications	192
histone acetylation	160
promoter regions	230
findings indicated	441
protective effects	450
family members	394
possible mechanisms	327
randomly divided	480
lactate dehydrogenase	578
neuroprotective effects	146
bone metastasis	571
including prostate cancer	103
benign prostate hyperplasia	113
different time points	160
significantly higher compared	243
prostate cancer cell lines	230
oral cancer	747
inflammatory response	876
oral mucosa	108
diphenyl tetrazolium bromide	103
reverse transcriptase polymerase chain reaction	158
enzyme linked immunosorbent assays	106
egfr inhibitor	113
human telomerase reverse transcriptase	208
risk factor	1149
japanese patients	523
detected using	222
mutation rate	133
aspartate aminotransferase	263
least years	138
hepatitis b virus	567
male patients	382
steroid hormones	116
could potentially	106
various stages	185
less effective	128
potential therapeutic agent	227
transcriptional regulation	572
disease pathogenesis	178
deregulated expression	117
subsequent activation	111
janus kinase	256
innate immune system	201
review highlights	130
nonalcoholic fatty liver disease	286
high density lipoprotein	164
logistic regression	468
high glucose	151
mesenchymal stromal cells	154
investigated whether	365
adipose tissue	790
culture medium	221
wound healing	959
hepatocyte growth factor	369
mesenchymal phenotype	186
epidermal growth factor	444
morphological changes	316
mesenchymal markers	262
cell morphology	325
emt markers	302
blood flow	100
vascular cell adhesion molecule	123
intercellular adhesion molecule	176
study demonstrated	915
may play	518
predictive values	109
many human cancers	296
predictive value	1098
clinical value	467
primary breast cancer	325
p53 mutations	131
molecular subtype	243
p53 mutation	141
overall survival rate	277
lymph node involvement	452
poor response	423
growing evidence	189
quantitative rt pcr	393
corresponding normal tissues	109
gc patients	794
high mir expression	126
low mir expression	157
stromal fibroblasts	118
hypoxic conditions	619
transwell assay	763
apoptotic rate	191
certain cancers	200
crc tissues	604
biopsy samples	136
p erk	281
matrix metallopeptidase	118
cell apoptosis	1639
induced cell apoptosis	299
crc cells	1236
negative control	293
confer resistance	115
co expression	512
cll cells	330
clinical evidence	180
mesenchymal transition	2176
human melanoma	180
melanoma cells	1172
novel target	689
aberrant expression	976
tumor suppressor genes	648
breast cancer cases	257
better prognosis	547
major contributor	100
treatment resistance	258
novel targets	162
select patients	266
clinical settings	233
treat cancer	189
homologous recombination	404
several genes	179
fanconi anemia	199
cisplatin resistance	514
normal skin	137
poorer survival	186
resistant cells	308
key factor	293
high affinity	452
mouse models	574
cytotoxic activity	555
results support	601
transcriptome analysis	106
cpg islands	160
p53 signaling pathway	159
cancer cell migration	186
analysis showed	263
may represent	415
antitumor effect	598
non small cell lung cancer cells	307
caspase dependent apoptosis	129
chemotherapeutic agents	687
selected cases	170
lung cancers	514
detection limit	215
mir 133a	142
flow cytometric analysis	446
invasion assays	385
human lung adenocarcinoma	110
hepg2 cells	1860
phorbol myristate acetate	127
also analyzed	606
chromatin structure	104
apoptosis rates	103
mechanistic basis	129
observational study	257
distant metastasis free survival	168
results compared	721
confidence intervals	1413
advanced stage disease	156
tumour tissue	144
hazard ratio confidence interval	123
cultured cells	245
helicobacter pylori	229
egf receptor	123
gastric mucosa	191
gastric carcinogenesis	226
pylori infection	242
increased compared	114
gene expression profile	261
basement membrane	111
tumor suppressor function	144
conditioned medium	395
invasive phenotype	210
metastatic lesions	323
melanoma progression	210
cardiovascular disease	1057
dna binding domain	137
dna binding	236
cell lysates	105
amino acids	478
could contribute	172
increasing incidence	149
early onset	174
commonly used	486
quantitative analysis	288
chinese population	1051
genetic studies	115
precise estimation	105
sensitivity analyses	148
meta analysis indicated	103
celiac disease	107
first degree relatives	115
refractory disease	138
study investigated	832
polymerase chain reaction restriction fragment length polymorphism	249
histological type	447
pi3k/akt signaling pathways	116
colon carcinoma	114
g2/m phases	112
smooth muscle cells	144
colorectal liver metastases	181
major challenge	373
liver regeneration	119
malignant pleural mesothelioma	315
clinical information	213
retrospectively collected	152
cox proportional hazards model	371
predicting survival	117
year overall survival rate	165
multivariate analysis indicated	174
greater risk	184
cox regression model	253
human epididymis protein	106
small cell lung cancer	785
serum samples	745
sclc patients	143
receiver operating characteristic curve	448
tumor markers	472
molecular diagnosis	153
cpg island methylator phenotype	139
epigenetic alterations	318
possible use	100
new method	166
transfected cells	176
dimethylthiazol yl	552
diphenyltetrazolium bromide assay	125
successfully constructed	104
panc cells	296
gastric cancer risk	203
case control studies	300
genetic polymorphisms	579
closely correlated	407
common malignancies	177
normal individuals	104
patient group	254
significantly greater	367
chronic gvhd	103
experimental models	189
il secretion	193
allogeneic stem cell transplantation	205
less frequent	118
less likely	461
available evidence	110
cytotoxic activities	153
similar results	441
obtained using	108
inflammatory breast cancer	112
zeste homolog	245
ezh2 expression	160
clinicopathologic features	823
evaluated using	608
triple negative tumors	105
receptor status	137
clinical implications	670
increasing interest	130
high proportion	181
also used	337
study revealed	513
protective role	410
intracellular reactive oxygen species	222
possible mechanism	486
background patients	247
remains controversial	143
downstream signaling	178
phosphoinositide kinase	454
multiple human cancers	105
akt activation	242
aberrant activation	410
background hepatocellular carcinoma	152
high tumor grade	102
prospectively enrolled	145
strong correlation	363
kinase activity	215
polymerase chain reaction	573
sds page	100
pilot study	645
disease outcome	163
expression status	273
tnf expression	101
uc patients	133
findings support	534
anti inflammatory effect	199
b cell lymphoma	784
recent reports	155
bcl bcl xl	116
small proportion	139
specific biomarkers	116
kras mutation	545
current standard	191
new approach	333
mir 200c	383
bioinformatics analysis	549
invasion capacity	132
ovarian cancer tissues	168
cell leukemia/lymphoma	161
sporadic cases	109
tumor aggressiveness	302
human studies	112
new insight	193
intellectual disability	119
immunohistochemistry analysis	150
inflammatory cells	307
study demonstrate	107
greater extent	146
brain metastases	967
surgery alone	173
treatment modality	159
median survival time	392
plasminogen activator inhibitor	138
greater number	152
intrahepatic cholangiocarcinoma	352
invasive front	196
clinicopathological factors	725
significant risk factors	100
may affect	108
may explain	184
papillary thyroid carcinomas	102
tumour growth	292
first demonstration	127
egfr tyrosine kinase inhibitors	389
met amplification	149
egfr pathway	108
imaging findings	157
us food	309
male sex	174
survival outcome	175
radical resection	196
independent prognostic factors	898
year dfs	162
survival rate	812
giant cell tumor	136
histological analysis	142
six months	255
complete resection	271
widely accepted	144
erectile dysfunction	107
low incidence	161
international prognostic index	132
approximately half	157
genetic variation	293
menopausal status	288
genetic variants	699
beneficial effects	419
leptin levels	126
also revealed	154
systemic diseases	121
analyzed retrospectively	272
results according	112
group b	793
independent factor	289
aml patients	816
conclusions compared	135
low expression group	100
vitamin c	134
alkaline phosphatase	393
phosphorylated akt	247
five patients	525
also seen	166
enhanced sensitivity	104
tumor necrosis factor related apoptosis inducing ligand	281
nlrp3 inflammasome	142
among others	212
enzymatic activity	368
conditioned media	252
invasive capacity	159
small subset	201
vast majority	434
significant proportion	305
women diagnosed	195
reliable marker	102
ovarian reserve	223
menstrual cycle	167
anoikis resistance	139
hepatocellular carcinoma cells	589
cck8 assay	128
different mechanisms	241
antiangiogenic agents	100
tumor antigens	114
clinical research	193
immune checkpoint inhibitors	757
tumor types	441
colorectal cancers	608
salivary gland	105
tissue remodeling	112
immune suppression	164
enzymes involved	114
cells exposed	202
critical roles	154
clinical responses	173
interferon gamma	308
ifn production	150
malignant disease	190
plasma cells	322
may influence	109
chronic disease	111
mrna expressions	211
insulin like growth factor	648
results among patients	189
hepatitis c	112
review provides	246
recent advances	879
pi3k/akt/mtor pathway	365
pituitary adenomas	407
new therapeutic approaches	146
pituitary tumors	122
tumor biology	373
prostate carcinoma	154
rare condition	122
human osteosarcoma	289
pancreatic cancers	194
osteosarcoma tissues	237
quantitative real time pcr	972
xenograft model	417
results imply	137
abnormally expressed	114
advanced prostate cancer	358
point mutation	132
bone loss	137
altered expression	527
studies demonstrate	184
promoter hypermethylation	291
huh7 cells	187
first described	135
histological findings	112
strongly positive	227
molecular analyses	102
first case	589
second case	126
year old boy	239
background prostate cancer	148
antioxidant enzymes	175
epithelial cells	821
induced cell death	140
dna fragmentation	372
results strongly suggest	119
neuroblastoma cells	348
neurodegenerative diseases	519
phase ii study	445
two thirds	188
phase ii	231
objective response	269
evaluated according	173
emerging role	244
malignant tumors	938
il 1ra	202
clinical activity	279
bone metastases	649
response rates	218
versus months	170
hr ci	1424
median pfs	768
multivariable analyses	186
small sample size	152
also implicated	109
nuclear translocation	748
mda mb	972
time course	130
decreased proliferation	151
apoptotic response	107
cell counts	121
cell adhesion	776
cell number	118
active surveillance	504
breast cancer diagnosis	175
stage ii	572
endocrine therapy	633
er negative	145
early stage breast cancer	312
tumor histology	121
recently described	176
vitro studies	416
human hcc	224
tgf pathway	148
cd44 expression	188
mir 34a	773
prostate cancer progression	312
mir 148a	225
study supports	155
ten patients	220
calculated using	281
standard deviation	217
examined using	174
human peripheral blood mononuclear cells	141
direct effect	178
hydrogen peroxide	319
immunomodulatory effects	125
combined analysis	175
promotes apoptosis	218
platelet counts	127
methods data	584
mutation status	420
advanced lung adenocarcinoma	112
lung squamous cell carcinoma	276
american society	333
european society	115
medical oncology	127
molecular pathology	138
conventional chemotherapy	377
autoimmune diseases	697
low frequency	202
allele frequencies	230
previously shown	627
year period	426
fasting insulin	152
also present	262
colon cancer	2441
rectal cancer	939
among women	118
functional role	901
insulin like growth factor receptor	265
glycogen synthase kinase	233
igf ir	140
erk1/2 phosphorylation	117
patients underwent	154
axillary lymph node dissection	100
background recently	109
prostate specific membrane antigen	262
allowed us	112
conclusions overall	219
promising tool	160
b7 h1	102
cell infiltration	244
b7 h4	209
positively related	187
poor differentiation	314
might contribute	164
emerging evidence suggests	118
notch signaling	351
specific role	189
clinical translation	136
several human malignancies	105
single institution	395
vascular invasion	755
h score	110
strong rationale	111
clinical evaluation	298
early breast cancer	434
recurrent disease	359
embase databases	152
also reported	185
mean number	222
limited data	234
secondary outcomes	170
four genes	118
breast carcinomas	206
p mtor	303
final analysis	232
outcome measures	113
subgroup analysis	745
lymph node status	351
therapy resistance	288
colony formation assay	450
hypoxia inducible factor alpha	137
cell growth inhibition	153
vegf expression	416
intraperitoneal injection	136
dna hypermethylation	142
including patients	322
significantly higher risk	155
colorectal adenoma	131
normal control	162
important biomarker	110
developing countries	212
aberrant dna methylation	123
pca risk	119
pca patients	345
several cancers	775
rcc patients	235
rcc cell lines	123
rcc tissues	113
potential prognostic biomarker	270
invasive lobular carcinoma	121
immunohistochemical stains	138
related proteins	141
invasion ability	474
invasive potential	268
studies showed	262
tumor cell invasion	147
cochrane library	660
grade adverse events	117
pulmonary embolism	114
mcrc patients	157
mechanistic studies	145
new drugs	282
p gp	1157
breast cancer resistance protein	260
oral administration	332
hardy weinberg equilibrium	125
skin cancer	463
murine models	161
oxidative dna damage	119
current smokers	106
molecular marker	129
cross sectional	114
tumor mass	155
clinical specimens	263
african american	189
obese women	228
large cohort	534
rotterdam criteria	107
study group	442
negative association	116
breast cancer progression	492
decreased levels	326
data provide	272
brca2 mutations	214
assessed using	688
stratified according	165
tnf il	242
normal tissues	1585
pancreatic cancer cell lines	194
highly potent	108
single agent	486
p53 pathway	226
antitumor activity	1231
dose limiting toxicities	230
also noted	131
therapeutic use	134
nsclc cell lines	359
either alone	162
potential candidate	238
mammalian cells	462
inhibit growth	101
cleaved parp	206
combined therapy	217
invasive properties	162
novel class	277
highly specific	176
c kit	574
alk rearrangements	163
results median follow	137
improved os	147
small noncoding rnas	100
tumor development	1204
also confirmed	341
hazard ratios	546
also significantly higher	171
colorectal carcinogenesis	239
crc progression	152
mann whitney u test	183
morphological features	139
mr imaging	127
current treatments	130
novel diagnostic	134
prognostic biomarkers	492
skov3 cells	250
key enzyme	226
protein synthesis	347
anticancer efficacy	152
promising therapeutic target	597
pi3k inhibitor	140
pten loss	229
pi3k inhibitors	174
inhibit cell proliferation	167
results highlight	372
silico analysis	236
may occur	111
pooled odds ratio	105
confidence interval ci	197
performed according	140
present study suggested	268
asian patients	207
cell culture	364
oral cancer cells	154
human mesenchymal stem cells	125
present study examined	160
fold higher	254
genetic changes	127
human malignancies	468
pten expression	313
one case	820
cervical cancer tissues	242
international federation	257
cell differentiation	544
positive rate	454
cervical carcinoma	305
parkinson's disease	457
single nucleotide polymorphism	396
main causes	137
cancer related mortality	204
lung cancer patients	1019
measured using	458
optimal cut	215
pleural effusion	319
pathological diagnosis	282
methylation level	163
anticancer agent	151
epigenetic changes	235
thymidylate synthase	204
neuroendocrine tumors	397
clinical investigation	188
demographic data	133
abdominal pain	376
unknown primary	114
primary tumors	1141
curative intent	280
year survival rates	284
clinical presentation	526
colon cancer patients	251
liver metastasis	647
therapeutic targets	952
clinical efficacy	706
genetic variations	273
genetic mutations	227
antiproliferative effects	284
individual patients	258
advanced non small cell lung cancer	900
best response	134
clinical usefulness	129
febrile neutropenia	370
aged years	521
elderly patients	1049
phase ii trial	285
cox inhibitors	101
primary site	223
treatment strategies	304
urgently required	149
endocrine resistance	130
frequently expressed	147
findings suggested	585
negative prognostic factor	126
potential strategy	227
survival time	567
gastrointestinal cancers	151
including colorectal cancer	116
significantly lower compared	103
two groups according	154
patients without	272
lymphatic metastasis	439
year overall survival rates	151
higher rates	247
tnbc patients	327
patient demographics	141
chi square	120
pr expression	105
significant predictors	374
biochemical failure	135
histone deacetylase inhibitor	145
cell therapy	492
tumor specific	105
cell function	335
il receptor	139
novel mechanism	897
host defense	128
activation status	101
improved understanding	224
neurofibromatosis type	980
many studies	464
genomic instability	478
adverse outcomes	109
time consuming	134
important step	102
mammary gland	174
functional significance	270
glioma progression	147
tube formation	417
il mrna	103
new role	145
estimated glomerular filtration rate	131
remain unknown	142
fisher's exact test	214
shorter survival time	130
enforced expression	252
phase arrest	237
nf Œ∫b activation	392
cancer growth	208
dna damaging agents	219
potential applications	151
increasing evidence	347
antigen presenting cells	278
novel therapeutic approaches	140
systemic chemotherapy	277
therapeutic agents	360
significant morbidity	148
radiofrequency ablation	226
one month	144
patients experienced	114
radiation therapy	1101
significant improvements	110
small number	409
independent predictive factor	130
retrospective analysis	1131
patient management	130
urgent need	506
predictive marker	321
recent data	139
identify patients	583
many patients	319
patients younger	124
patients years	179
graft versus host disease	228
plasmacytoid dendritic cells	106
immunohistochemically stained	124
statistically significant increase	132
year old female patient	194
patients present	110
worst prognosis	126
strong expression	185
cancer research	383
tumor uptake	101
successfully applied	119
end stage renal disease	171
six cycles	185
first case report	116
disease characteristics	133
median time	739
progression free	261
common cause	658
positive effect	134
langerhans cell histiocytosis	127
new therapeutic target	248
combined treatment	925
adult patients	690
three patients	771
frequently used	187
bone marrow microenvironment	140
selected genes	152
higher proportion	231
positive cells	242
data confirm	108
egfr inhibitors	337
high prevalence	471
conducted using	196
baseline characteristics	225
shorter survival	324
conventional therapies	151
various cancers	1533
wound healing assay	529
f actin	120
study highlights	316
histologic features	137
skin cancers	124
study participants	107
squamous cell carcinomas	427
perineural invasion	401
western blot assay	293
three cases	442
seven patients	352
imaging features	151
four patients	593
k562 cells	562
ic50 Œºm	143
comet assay	181
caspase activation	665
18)f fdg pet/ct	140
invasive breast cancer	500
apparent diffusion coefficient	181
er status	186
multivariate analysis showed	564
imaging studies	163
treatment strategy	240
risk stratification	537
severe sepsis	109
genetic characteristics	102
adrenocorticotropic hormone	169
increased level	243
similar pattern	100
disease activity	501
skeletal muscle	343
fold change	190
significant changes	459
serum il	136
r p	630
study assessed	147
frequent cause	138
well tolerated	1323
prospective studies	390
bone metabolism	120
low dose	298
later stages	144
mir could	114
intestinal metaplasia	166
body fluids	114
hsa mir	281
target mrnas	107
catalytic activity	227
human health	257
study sought	200
methods blood samples	111
whole blood	250
used immunohistochemistry	102
expression patterns	537
metabolic parameters	166
also higher	209
whole cohort	133
routine use	100
programmed death	332
pd expression	158
direct effects	130
pharmacological inhibition	683
directly binding	197
cell cycle regulation	461
amino acid	111
molecular dynamics simulations	168
traditional medicine	129
estrogen receptor alpha	203
c peptide	148
older women	126
physiological processes	131
nucleotide excision repair	176
c terminus	253
poor clinical outcome	399
human ovarian cancer	147
receptor tyrosine kinase	245
cox regression analyses	154
aromatase inhibitors	286
postmenopausal patients	117
nine patients	332
rt qpcr	1034
tumor proliferation	217
ionizing radiation	629
adenoid cystic carcinoma	241
rare case	768
right breast	103
also discussed	324
anti inflammatory activity	160
thp cells	261
recommended dose	131
mixed lineage leukemia	127
potential mechanism	484
also suggest	102
three types	165
mhc class	264
advanced pancreatic cancer	152
hpv positive	175
neck squamous cell carcinomas	219
human papilloma virus	199
novel therapeutic targets	237
sanger sequencing	657
gleason score	1044
pathologic stage	151
prostate cancers	314
lymphatic vessels	138
her2 positive metastatic breast cancer	127
overcome resistance	237
last decades	166
treg cells	394
predictive biomarkers	551
therapeutic interventions	201
aggressive form	183
brain tumor	132
anti proliferative effects	229
lung metastases	274
china national knowledge infrastructure	169
primary outcome	495
cancer cell growth	246
figo stage	252
statistical significance	556
findings show	383
tensin homolog	436
methods immunohistochemistry	246
kaplan meier analysis	529
log rank tests	139
poorer overall survival	222
negative predictive values	156
p p38	134
prognostic effect	143
immunohistochemistry staining	184
clinical stage	1266
early stage	1031
distant metastases	780
emerging evidence	201
chinese national knowledge infrastructure	121
random effect model	112
also performed	608
prostate cancer tissues	146
prostate carcinogenesis	111
inducible nitric oxide synthase	265
nitric oxide	634
vascular endothelial growth factor receptor	382
clear cell rcc	152
stem cell factor	136
mast cells	473
adjacent normal tissue	225
lymph node	640
wnt/Œ≤ catenin pathway	508
breast cancer stem cells	221
n cadherin	1039
mmp mmp	190
mmp expression	579
clinical potential	163
lung metastasis	515
cells derived	115
molecular modeling	111
medullary thyroid cancer	137
locally advanced	486
protein protein interactions	235
potential impact	198
tnf levels	275
positive patients	103
significant positive correlation	260
hcv infection	260
critical regulators	122
biological effects	434
pulmonary hypertension	104
chronic obstructive pulmonary disease	475
patients undergoing surgery	108
laparoscopic surgery	157
open surgery	138
patients showed	171
available data	240
surgical approach	139
rectal cancer patients	147
imatinib mesylate	177
cml patients	325
heme oxygenase	257
nuclear factor erythroid related factor	127
cell response	360
human body	181
limited efficacy	131
fine needle aspiration	248
nuclear staining	144
early phase	193
bone marrow cells	131
cellular functions	264
previously associated	127
tgf signaling	360
high morbidity	206
bronchoalveolar lavage fluid	139
downstream effector	160
data presented	124
p38 mitogen activated protein kinase	218
transcriptional activation	284
advanced melanoma	446
braf inhibitor	127
mek inhibitor	225
also obtained	100
braf inhibitors	358
novel therapies	332
major source	128
localized disease	115
metastatic cancer	210
regulatory role	335
cervical cancer cells	784
useful tool	438
initial presentation	175
f fdg pet/ct	114
aurora b	161
cellular stress	152
cell division	330
ewing sarcoma	455
genes encoding	156
target gene	729
colorectal cancer cell lines	135
dual luciferase reporter assay	333
cells transfected	316
liver cancer cells	325
two weeks	114
pathological examination	179
surgical specimens	325
pathway analysis	235
cell cycle distribution	563
protein expressions	594
a549/ddp cells	153
regulated expression	253
rna interference	604
sw480 cells	298
high concentration	169
colorectal cancer tissues	204
c myc expression	171
histological differentiation	126
transwell migration assay	139
advanced gastric cancer	476
adverse effect	158
twice daily	108
disease control rate	430
npc tissues	121
npc cells	451
common cancers	222
female patients	506
cardiovascular risk	115
cystatin c	149
glial fibrillary acidic protein	169
diagnostic marker	236
extracellular space	122
ischemic stroke	194
p trend	100
limited information	115
including cases	240
pooled odds ratios	172
longer duration	100
anti epidermal growth factor receptor	106
serine/threonine kinase	132
anti egfr therapy	187
pathway enrichment analysis	131
treated patients	231
median survival	749
stereotactic radiosurgery	130
potential benefit	132
objective response rate	563
unselected patients	111
gene mutation	127
ci respectively	235
log rank	193
breast cancer specific survival	100
neck cancers	266
mainly due	213
significant number	207
hnscc patients	220
close proximity	130
methylation levels	182
pre treatment	368
year overall survival	649
local control	179
hr ci p	332
key component	267
pi3k pathway	244
novel agents	296
article reviews	253
second line chemotherapy	181
median duration	391
epithelial markers	148
cancerous cells	182
two types	346
zeta potential	204
anti inflammatory	775
first diagnosis	100
double blind	560
acute myocardial infarction	104
well studied	295
luminal b	378
chinese women	140
morphologic features	128
triple negative	689
poorly differentiated	208
advanced glycation end products	228
clinical impact	349
two proteins	214
co expressed	158
significantly related	491
stage iii	534
molecular target	231
driver mutations	227
carcinoembryonic antigen	687
interferon regulatory factor	121
human serum albumin	147
vice versa	226
human patients	153
intracellular accumulation	148
rna sequencing	368
caucasian population	108
papillary thyroid cancer	477
ptc patients	204
primary aldosteronism	188
increased production	200
catalytic subunit	254
cushing's syndrome	146
direct sequencing	473
primary cells	160
immunofluorescent staining	117
new therapeutic targets	136
tyrosine kinase	106
current knowledge	599
physiological functions	120
human diseases	435
molecular level	599
mortality worldwide	111
low sensitivity	141
human melanoma cells	196
nuclear export	120
vitro effects	131
mts assay	156
pro apoptotic effects	179
nuclear accumulation	186
potential therapeutic approach	137
cerebrospinal fluid	414
two cohorts	190
advanced nsclc patients	170
chemotherapy treatment	114
shorter pfs	140
hr p	350
advanced nsclc	620
egfr gene	157
prostaglandin e2	275
dual inhibition	162
major obstacle	312
nsclc patients	1827
shorter overall survival	554
rapamycin complex	196
advanced stages	540
frequently detected	205
positive predictive value	623
direct targets	136
rna seq	346
chip seq	127
metastatic breast cancer	956
chronic periodontitis	114
main objective	141
clinical parameters	705
granulocyte macrophage colony stimulating factor	216
previous work	223
related genes	136
eastern cooperative oncology group performance status	161
high risk groups	144
independent cohort	321
thioredoxin reductase	108
clinical trial	565
dose limiting toxicity	182
metastatic progression	268
reduced survival	196
survival data	295
tissue microarrays	517
tumour microenvironment	264
advanced colorectal cancer	172
inflammatory mediators	397
frequently mutated	272
endometrial cancers	160
key components	144
tyrosine kinase inhibitor	433
retrospective cohort	121
prospective cohort	137
consecutive cases	109
never smokers	309
tumor associated antigens	151
plasma levels	609
il expression	388
stably transfected	139
human umbilical vein endothelial cells	500
co immunoprecipitation	280
carbonic anhydrase ix	178
triple negative breast cancers	297
metastasis free survival	189
key players	230
innate immunity	356
c met expression	112
important cause	136
regulating cell proliferation	106
egfr signaling	187
cell leukemia virus type	101
atp binding cassette	218
small molecule inhibitor	278
multidrug resistance associated protein	126
major risk factor	172
data highlight	172
cells cultured	121
attractive therapeutic target	245
new avenue	128
egfr amplification	121
immunohistochemical features	238
low level	412
acute myelogenous leukemia	167
anti proliferative	244
positron emission tomography/computed tomography	104
two years	205
sentinel lymph nodes	107
disease recurrence	562
solitary fibrous tumor	142
ki labeling index	128
lynch syndrome	621
dna mismatch repair	142
germline mutation	263
patients died	299
small size	110
cancer stage	150
chronic pancreatitis	476
pancreatic cancer tissues	145
carbohydrate antigen	248
bcl family proteins	141
pulmonary fibrosis	169
accumulating evidence	244
critical regulator	292
bcl family	223
ex vivo	203
brain derived neurotrophic factor	214
anti cancer effects	290
human glioblastoma cells	173
apoptotic effect	221
metastatic renal cell carcinoma	551
clinicopathologic factors	182
median progression free survival	826
renal tumors	111
germline mutations	639
data obtained	215
metastatic dissemination	136
metastatic spread	311
long term survivors	109
life expectancy	167
crp levels	181
treatment efficacy	233
cell membrane	491
clinical effectiveness	107
study reports	164
statistical analyses	373
including age	138
well recognized	127
dose escalation study	110
advanced solid tumors	326
maximum tolerated dose	461
day cycle	176
one patient	1205
egfr mutation status	236
first line	419
better response	173
p however	450
longer pfs	140
prognostic indicators	115
univariate analyses	163
r0 resection	147
cervical cancer cell lines	144
methylation specific pcr	268
caski cells	102
real time rt pcr	289
markedly reduced	191
mir inhibited	149
promoted apoptosis	352
novel therapeutic strategy	353
common mutations	100
gain insight	183
lovo cells	183
three dimensional	235
highest level	125
genetic background	152
cancer cell	287
esophageal cancer cells	206
dose dependent increase	109
prognostic relevance	332
investigate whether	516
disease specific survival	464
cox proportional hazard models	103
genetic susceptibility	237
alcohol intake	123
highest risk	167
differential effects	170
ethanol extract	109
dose‚Äëdependent manner	144
findings demonstrated	304
binding affinity	296
p selectin	104
mutational analysis	199
crystal structure	322
data provide evidence	124
glucose regulated protein	107
co localized	120
despite advances	146
accumulating evidence indicates	117
binding protein	206
inverse relationship	215
tumor suppressor	2798
human glioblastoma	168
dynamic changes	122
carbonic anhydrase	112
certain types	241
nadph oxidase	158
electrophoretic mobility shift assay	109
significantly attenuated	126
mevalonate pathway	117
helper cells	117
prognostic prediction	119
significantly downregulated	992
clear cell	178
fuhrman grade	104
radical prostatectomy	903
descriptive statistics	121
reference standard	124
thus far	178
anti tumour necrosis factor	108
anti tnf	393
methods using	256
cox regression	334
female sex	122
two cases	780
recurrent tumors	126
aggressive subtype	129
metabolic pathways	175
adenosine triphosphate	108
renal function	379
high rate	523
bonferroni correction	122
controls vs	103
study reveals	400
ataxia telangiectasia	109
genetic instability	102
cancer susceptibility	278
patients compared	239
growth hormone	349
therapeutic option	171
oral squamous cell carcinomas	150
oscc cells	318
two independent cohorts	136
pathological grade	203
experimental studies	168
study provides evidence	204
active disease	121
autoimmune disease	226
paired samples	124
primary objective	315
ovarian cancer risk	114
free radicals	110
well documented	353
could lead	172
tamoxifen resistance	167
principal component analysis	156
actinic keratosis	138
cells isolated	106
tumor tissue samples	101
key regulators	378
healthy people	150
several human cancers	281
first years	166
meta analysis showed	196
peritoneal metastasis	239
useful marker	287
serum concentration	133
logistic regression analysis	266
papillary thyroid carcinoma	989
adjacent non cancerous tissues	220
tumor node metastasis	247
clinical staging	179
notch pathway	165
healthy tissue	108
decreased level	123
also compared	204
vivo effects	115
colon cancer cell lines	170
adenomatous polyposis coli	152
platelet count	305
previous research	120
pap test	152
heterogeneous group	390
give rise	181
dna methyltransferases	119
b cell acute lymphoblastic leukemia	142
age groups	209
findings showed	209
toxic effects	187
new class	414
oxidative phosphorylation	283
present study indicated	292
crc cases	122
mcf7 cells	322
microscopic examination	103
peripheral blood samples	241
predict prognosis	162
hcc development	321
various organs	129
also conducted	198
transwell migration	154
particular emphasis	122
hb egf	129
clinical samples	531
hoechst staining	255
chinese han population	330
cancer free controls	173
genotype distribution	115
also related	132
tumor burden	287
pharmacologic inhibition	223
pancreatic tumors	129
cell membranes	122
potential implications	146
independent set	110
clinical prognosis	168
clinicopathological variables	292
identify factors associated	106
systemic therapy	406
biopsy specimens	201
combination chemotherapy	216
granulocyte colony stimulating factor	378
g csf	707
proto oncogene	125
burkitt lymphoma	178
co occurrence	123
histological features	196
long term outcomes	363
month follow	316
gastric carcinoma	583
aggressive cancer	117
anti apoptosis	119
gc tissues	449
data revealed	286
novel function	270
indoleamine dioxygenase	197
short hairpin rna	183
tumor specimens	272
tt genotype	308
higher number	195
pathological stage	308
also significantly associated	154
multivariate logistic regression analysis	169
group patients	100
mismatch repair	225
unknown significance	107
highly conserved	120
mean sd	115
cardiovascular risk factors	143
highly correlated	324
histone methylation	118
histone h3	264
low doses	262
wnt/Œ≤ catenin signaling pathway	505
enhanced proliferation	103
collagen type	114
promoting cell proliferation	100
inhibiting apoptosis	106
circulating tumor cells	814
selection criteria	103
blood cells	156
lncap cells	523
enhanced apoptosis	189
tumor volume	595
mutation carriers	150
quantitative reverse transcription pcr	121
studied extensively	109
tumour size	344
adjusted hazard ratio	214
matched normal tissues	148
chronic kidney disease	412
objective patients	110
cardiovascular events	174
conclusions taken together	375
neck cancer	947
range months	274
potent inhibitors	177
human prostate cancer cells	208
clinical stages	185
tumor differentiation	548
histological grade	762
western blot showed	112
attractive strategy	133
cancer prevention	315
molecular docking studies	119
mapk signaling pathways	100
treated cells	226
g2/m cell cycle arrest	131
stage iv disease	152
chronic myelogenous leukemia	232
p53 protein	288
study focused	122
median months	117
caspase expression	133
phosphatidylinositol kinase	526
bone marrow stromal cells	109
selective inhibitor	311
selective inhibition	183
older age	471
initial treatment	293
selected patients	385
prolonged survival	305
initial therapy	148
randomized clinical trials	164
translational research	123
increased mortality	161
overall mortality	164
cancer specific mortality	138
mitochondrial respiration	113
potential therapeutic targets	499
cells within	100
catenin signaling	120
high performance liquid chromatography	141
also detected	551
mesenchymal cells	132
monoclonal gammopathy	179
undetermined significance	269
treatment failure	587
sex determining region	133
cancer stemness	116
unknown etiology	103
tnf interleukin	318
anti tnf agents	192
neutrophil lymphocyte ratio	112
observations suggest	270
highly aggressive	133
great importance	225
dynamic light scattering	118
diphenyltetrazolium bromide	405
important factor	341
immune function	238
tnf alpha	267
last years	448
stage iiib	122
assessed according	107
cancer related death	380
underlying cause	110
sphingosine phosphate	149
sphingosine kinase	140
shown promise	165
evidence suggests	252
novel strategy	485
drug targets	151
telomerase activity	356
new series	124
digestive tract	100
insulin secretion	163
food intake	155
broad range	380
genes coding	101
various cancer types	236
genotype frequencies	151
turkish population	101
second leading cause	399
siha cells	236
expression rate	127
methylguanine dna methyltransferase	130
vitro experiments	262
glioblastoma patients	216
ovarian cancers	391
peritoneal fluid	105
single cells	167
gastric cancer progression	119
underwent surgery	506
extremely rare	580
dramatically increased	101
normal counterparts	135
downregulated expression	120
reduced risk	412
hcc risk	153
microvascular density	112
wnt/Œ≤ catenin	240
asian populations	204
potential tumor suppressor	138
present meta analysis	143
control tissues	104
liver tissues	149
hepatitis c virus	536
hcc diagnosis	118
ankylosing spondylitis	331
correlation analysis	208
wide variety	655
insulin levels	129
small intestine	306
acute lymphoblastic leukemia	1033
solid tumours	239
tumor necrosis factor receptor	113
optimal management	127
akt signaling	203
patient samples	328
promote tumorigenesis	134
downstream target	265
viral infection	247
present study demonstrates	151
inflammatory cytokines	967
replication stress	159
heart disease	126
mir 29a	190
body fat	147
tightly regulated	208
plasma membrane	847
sri lanka	108
cathepsin b	181
migration assays	153
human papillomavirus	884
potential benefits	147
african americans	230
protein stability	170
pca cell lines	120
hdac inhibitors	251
nf1 patients	146
malignant peripheral nerve sheath tumors	113
overall survival rates	232
nf1 gene	104
personal history	116
genetic counseling	243
elevated risk	218
p16 expression	248
salivary glands	224
high incidence	498
exceedingly rare	115
several years	103
histopathological findings	138
rare malignancy	109
english literature	122
spindle cells	184
tissue inhibitor	264
primary lesion	150
stomach cancer	109
current study aimed	168
immunofluorescence staining	334
forced expression	441
autophagy inhibitor	135
cell death induced	157
apoptotic pathway	128
ligand binding	109
cyclin e	350
retinoblastoma protein	130
predictive role	186
statistical differences	137
powerful tool	202
self renewal	853
annexin v	182
cost effectiveness	627
high throughput sequencing	123
prospective observational study	126
studied patients	134
mtor inhibitors	448
selecting patients	149
also induced	110
cell density	104
recessive model	337
asian population	200
rna polymerase ii	120
bone mineral density	191
lumbar spine	115
higher incidence	457
highly prevalent	125
national institutes	125
unacceptable toxicity	163
cutaneous melanoma	357
year old female	528
high dose chemotherapy	138
autologous stem cell transplantation	220
randomized trial	168
common complication	114
overall incidence	141
pdac patients	272
mitogen activated protein kinases	198
saudi arabia	132
master regulators	100
survival rates	490
os rates	116
prognostic evaluation	111
various cancer cells	214
performed using	915
even though	312
improved overall survival	199
predict response	193
hla g	237
kaposi's sarcoma associated herpesvirus	130
major causes	195
cancer death worldwide	125
recently emerged	206
ags cells	256
colon cancer tissues	117
human hepatocellular carcinoma	638
cell proliferation assay	110
proliferation rate	315
negative control group	156
invasion abilities	303
reverse transcription pcr	124
higher compared	121
also decreased	181
significantly better	302
model group	129
flow cytometry showed	102
time dependent	120
mtor signaling pathway	142
treatment group	339
pathological changes	100
decreased significantly	192
acute leukemia	495
observation group	375
different groups	177
blood glucose	126
great potential	390
stat3 activation	195
a431 cells	132
hacat cells	179
gc cells	650
transwell invasion assay	130
could serve	302
notch signaling pathway	197
lung tissue	155
small cell carcinoma	276
combined detection	160
proliferation index	107
multivariate analyses showed	104
malignant behavior	159
thyroid transcription factor	187
rare tumor	219
diagnostic biomarkers	116
total cholesterol	318
high doses	217
regulatory cells	151
specific marker	155
recent work	139
myeloid cells	370
hepatocellular carcinomas	170
special focus	135
pivka ii	139
p p respectively	119
glial cells	145
patients enrolled	317
mortality rates	258
prostate cancer diagnosis	121
cell count	154
circulating levels	277
less clear	118
longer follow	150
nested case control study	152
findings may	150
work demonstrates	126
mir acts	146
histone modification	102
histone deacetylase	560
nsclc tissues	490
b cell lymphomas	211
first cycle	225
genome stability	133
cellular senescence	378
tissue repair	133
epigenetic regulators	110
senescent cells	132
previous reports	328
pathological findings	169
her2 positive breast cancer	514
progenitor cells	366
roc analysis	134
adrenal glands	103
large proportion	189
hla class	281
rare entity	214
malignant neoplasms	130
lower rate	136
progesterone receptors	240
antioxidant activity	147
cognitive impairment	178
folic acid	155
predicting response	128
laryngeal cancer	274
oestrogen receptor	179
confocal microscopy	411
esophageal carcinoma	233
gestational age	145
often observed	112
two genes	251
negatively related	106
anti oxidant	112
anti tumor	134
anti inflammatory activities	131
methylation status	827
p hr	100
hiv infection	388
breast cancer susceptibility	151
human serum	187
cancer chemotherapy	300
biological activities	318
anticancer agents	403
human cervical cancer	112
antitumor activities	168
mgc cells	108
future development	166
p lymph node metastasis	108
whereas knockdown	189
first treatment	101
mutational status	332
significantly changed	112
healthy control subjects	180
pcos patients	442
visceral adipose tissue	135
higher level	386
biliary tract cancer	110
hh pathway	103
mirna expression profiles	115
lactate production	192
current status	324
molecular biomarkers	156
endometrial carcinoma	515
p53 status	243
high grade gliomas	264
mir 34c	100
potential targets	488
lower levels	510
important mediator	164
g2/m arrest	122
western blotting analysis	208
escc cells	396
eight patients	326
patient's age	124
shorter time	146
cervical intraepithelial neoplasia	267
cumulative incidence	319
non hodgkin lymphoma	498
year disease free survival	179
also investigated	669
potential application	335
therapeutic applications	195
small fraction	123
many malignancies	107
growth inhibitory effect	131
pi3k/akt signaling pathway	431
new insights	268
year old male	580
chronic liver disease	196
negative predictive value	566
culture supernatant	105
bgc cells	108
experimental group	378
plasma concentrations	226
proteasomal degradation	307
chemical inhibition	107
erk phosphorylation	150
developing cancer	102
interstitial lung disease	117
resistance mechanisms	198
long term treatment	167
sle patients	116
multiple comparisons	126
personalized treatment	141
trastuzumab resistance	127
provide insight	161
cancer immunotherapy	798
randomized clinical trial	162
significant interaction	126
pcr rate	145
nab paclitaxel	188
among patients	728
various malignancies	344
including breast cancer	241
metastatic sites	273
hormone receptor positive	310
pcos women	238
control women	105
vitro model	384
long non coding rnas	728
rapid development	102
immune evasion	202
spry4 it1	133
useful biomarkers	105
subcutaneous injection	128
results identify	131
also demonstrate	215
human pancreatic cancer	147
g protein coupled receptors	200
mir 200b	186
microvascular invasion	186
hcc samples	146
findings highlight	315
utmost importance	101
western blot analyses	352
ubiquitin proteasome pathway	110
treatment patterns	115
steady state	128
induction chemotherapy	321
methylenetetrahydrofolate reductase	119
low toxicity	184
analyzed according	106
follicle stimulating hormone	216
oropharyngeal squamous cell carcinoma	196
hpv status	252
human non small cell lung cancer	230
increasingly used	192
sensitivity analysis	183
unclear whether	145
dna methyltransferase	209
bone destruction	108
developed based	102
human tissues	166
basic research	110
epidemiological studies	206
cancer incidence	188
fundamental role	184
zoledronic acid	221
medical treatment	202
genotoxic stress	133
death receptor	193
apoptosis proteins	115
precise mechanisms	110
cancer deaths	152
pathogenic role	126
mesenchymal stem cells	499
partial remission	135
marked increase	199
complex interplay	101
chronic diseases	185
somatic mutation	180
downstream effectors	209
cellular mechanisms	109
liver injury	158
soft tissue	252
tumour development	119
primary end point	568
metastatic crc	155
sw620 cells	206
mapk signaling pathway	163
often difficult	104
nuclear factor	415
breast tissue	120
whole genome sequencing	147
apoptosis rate	455
normal lung tissues	167
drug discovery	261
corresponding confidence intervals	132
chronic hepatitis c	197
depressive symptoms	204
positive family history	122
brca1/2 mutations	135
recurrent mutations	149
telomere length	284
tuberous sclerosis	163
leading causes	440
lung cancer tissues	207
protein kinase b	319
promote tumor growth	123
high grade serous ovarian cancer	190
treatment effect	130
also studied	253
nonalcoholic steatohepatitis	133
metabolic disorders	249
immune cells	1063
inflammatory microenvironment	118
solid malignancies	120
oxidative damage	193
background although	112
obese individuals	102
germ cell tumors	105
strong association	309
directly related	105
frequently found	216
flt3 itd	306
idiopathic pulmonary fibrosis	131
tumour suppressor	224
growing body	258
p53 expression	575
rcc cells	330
therapeutic strategies	517
positive results	112
developing breast cancer	149
brca1 mutation carriers	102
significantly enriched	314
often used	158
quantitative real time polymerase chain reaction	739
molecular targets	263
significantly higher levels	213
data analysis	187
breast cancer therapy	219
constitutively activated	126
c c motif	165
early relapse	101
cell leukemia	175
various kinds	108
herein report	189
total bilirubin	123
cells expressing	194
preclinical model	108
genetic factors	240
viral infections	245
important regulators	238
breast cancer prognosis	109
highly dependent	128
identified genes	127
cell cycle regulators	118
signal transducers	116
serum markers	114
quantitative reverse transcriptase polymerase chain reaction	103
cytokine levels	238
th17 cells	310
southern china	119
early stage disease	191
optimal treatment	161
end results	195
received chemotherapy	196
low risk prostate cancer	120
effective strategy	336
recent discovery	103
calr mutations	157
essential thrombocythemia	279
primary myelofibrosis	263
clinical signs	134
whereas overexpression	148
first identified	174
anti cancer	142
isolated compounds	103
rational design	208
completely understood	290
median age years	265
important component	195
ebv infection	172
monocyte chemoattractant protein	176
anti tumor necrosis factor	287
systematic reviews	177
american college	163
human cancer cell lines	320
animal studies	172
chronic exposure	156
possible relationship	112
tumor hypoxia	131
endometrial cancer cells	175
ishikawa cells	161
tumor metastasis	872
still controversial	264
human monocytes	115
tumor cell lines	261
ovarian cancer cell lines	223
structure activity relationships	165
anti cancer activity	302
pro apoptotic proteins	107
tnf related apoptosis inducing ligand	123
rna binding proteins	132
chemo resistance	216
upregulated expression	203
targeted cancer therapy	117
may act	189
small molecule inhibitors	444
pancreatic carcinoma	170
dna damage repair	279
multiple genes	100
abnormal expression	425
nuclear localization	347
biological behaviors	127
precise mechanism	128
ataxia telangiectasia mutated	202
dna double strand breaks	344
erk activation	127
alpha fetoprotein	524
molecular biology	264
genetic polymorphism	132
macrophage migration inhibitory factor	141
metabolic diseases	185
research progress	104
clinical analysis	119
epigenetic mechanisms	230
histone modifications	162
radical nephrectomy	139
western world	131
b lymphocytes	232
tamoxifen treatment	106
male breast cancer	160
breast cancer tissue	154
cox regression analysis	334
thyroid carcinoma	293
transfection efficiency	135
genes related	356
c allele	279
os cells	400
os tissues	147
os patients	142
psoriatic arthritis	281
systemic lupus erythematosus	348
bone formation	162
important determinant	113
systematic analysis	139
hedgehog signaling pathway	114
xenograft mouse model	241
uterine cervix	273
younger patients	385
hr hpv	202
du145 cells	312
western countries	294
present study showed	164
long term outcome	252
induction therapy	243
pathologic response	104
molecular classification	196
first step	189
vegf receptor	125
important factors	130
published studies	187
polycythemia vera	333
functional characterization	220
mmp activity	140
epithelial phenotype	135
von hippel lindau	223
also reviewed	124
strong predictor	135
standard chemotherapy	289
results among	456
mir 18a	155
fat mass	184
metformin treatment	112
multiple tumors	173
hcc tissues compared	146
high expression levels	243
ki expression	317
heat shock proteins	194
ubiquitin proteasome system	209
extracellular signal regulated kinases	110
epithelial ovarian carcinoma	112
usually associated	146
primary diagnosis	128
laboratory tests	101
estimated using	210
long term	291
signal transduction pathways	110
c jun n terminal kinase	338
conclusions collectively	128
mapk pathways	147
inflammatory responses	364
background micrornas	194
mir mir	371
digestive system	114
important target	220
also able	171
present investigation	108
cyclin b1	374
merkel cell carcinoma	175
immunohistochemical studies	157
mutation analysis	242
many cancer types	180
fdg pet	200
negative patients	138
directly targeting	151
biological characteristics	280
bovine serum albumin	135
warburg effect	543
gastrointestinal cancer	198
breast cancer subtypes	272
ar expression	194
disease free	294
pathological complete response	293
invasive cancer	121
may also	227
ewing's sarcoma	134
hodgkin lymphoma	334
n acetyl l cysteine	118
promising candidate	298
dna synthesis	200
braf mutation status	110
american joint committee	233
oncogenic mutations	145
positive lymph nodes	226
tissue regeneration	118
induced pluripotent stem cells	140
embryonic stem cells	195
apoptosis related proteins	223
mitochondrial apoptotic pathway	127
potential roles	298
selective targeting	105
taking advantage	114
glucose uptake	219
cellular growth	142
wide array	124
genome wide analysis	113
methylation specific polymerase chain reaction	116
promoter methylation status	115
statin use	101
vasculogenic mimicry	197
blank group	130
wnt/Œ≤ catenin signaling	437
cancer patients treated	101
clinical oncology	221
significantly increased risk	344
drug target	145
related mechanisms	107
four cycles	191
p patients	307
administered orally	113
promote cell proliferation	116
antiproliferative effect	250
study included patients	324
conclusions despite	112
p53 dependent manner	102
stable knockdown	104
cisplatin treatment	253
effective treatments	201
tumour grade	115
post transcriptional regulation	206
suppressive effect	190
mortality rate	212
malignant lesions	266
studies revealed	155
present study suggests	183
time point	187
targeted therapeutics	110
mir 10b	227
anticancer properties	205
ht cells	387
dna replication	467
n terminal domain	118
cell transformation	125
tensin homolog deleted	140
her2 overexpression	229
regulatory mechanisms	304
methods pubmed	168
ingenuity pathway analysis	130
normal liver tissues	120
network analysis	130
effective method	202
cancer related death worldwide	236
microarray data	236
gene expression omnibus	373
study examined	209
pd l2	203
pd l1 expression	1387
colonic mucosa	108
adoptive immunotherapy	108
pyruvate kinase m2	120
cancer cell invasion	183
cytokine production	334
unmet need	115
tumour cells	744
polycomb repressive complex	176
biological roles	247
remained elusive	128
akt phosphorylation	294
increased sensitivity	280
promising therapeutic approach	161
aggressive malignancy	157
specifically expressed	138
cytokine expression	117
transarterial chemoembolization	185
early recurrence	256
tnm staging	335
diagnostic markers	113
two cycles	157
fdg uptake	117
year pfs	141
favorable outcome	201
better overall survival	219
better os	172
deep sequencing	153
clonal evolution	171
daily practice	118
older adults	224
molecular subtypes	486
aggressive tumors	196
retinoic acid	234
growing number	165
immune checkpoint blockade	279
lymphocyte associated antigen	152
anti pd	169
increased survival	177
high potential	133
known regarding	220
negative impact	218
infected cells	183
igf 1r	567
improve survival	212
new treatments	127
liver transplantation	555
new strategies	180
invasion assay	180
randomly selected	139
retrospective review	541
low density lipoprotein	173
neoadjuvant therapy	409
surgical procedures	107
nodal involvement	179
histopathological examination	284
decreased overall survival	137
independent risk factors	491
future directions	257
preliminary study	214
cancer stem cells	1750
tumor initiating cells	156
abc transporters	199
radiation treatment	152
white adipose tissue	224
human chorionic gonadotropin	189
luteinizing hormone	220
many diseases	256
tumorigenic potential	130
malignant diseases	156
effector cells	112
physiological conditions	172
cellular response	307
year old man presented	232
s100 protein	154
correct diagnosis	228
egfr tki treatment	135
fdg pet/ct	200
metabolic activity	124
activating mutations	381
korean patients	161
nuclear expression	256
dendritic cell	137
dose dependent	219
pregnant women	258
tumor resection	204
new approaches	115
also shown	303
shown promising results	149
cancer therapies	177
disease onset	130
genome wide association study	214
tumor growth inhibition	127
multiple cancers	366
systemic therapies	104
particular focus	178
oncologic outcomes	179
chronic infection	110
western blot analysis showed	196
lower incidence	171
chemotherapy alone	268
t24 cells	225
study design	285
second line setting	112
biologic agents	122
brca1/2 mutation carriers	144
tumor weight	113
young adults	584
bm mscs	181
key factors	134
tenascin c	136
rarely reported	193
year old girl	209
young patients	409
unusual presentation	120
selective inhibitors	209
parp inhibitor	115
caspase activity	524
parp cleavage	223
hep3b cells	191
a375 cells	118
transcriptional level	280
hpv infection	458
significantly worse	185
human plasma	172
advanced renal cell carcinoma	169
valuable tool	191
therapeutic drug monitoring	106
b cll	112
patient presented	234
critical factor	102
tumor suppressor p53	243
metastatic cells	109
increased number	283
diabetic retinopathy	102
cytochrome p450	202
coding regions	100
hek293 cells	167
mapk pathway	338
general anesthesia	134
aggressive clinical course	183
disease duration	103
different degrees	101
normal development	175
tissue homeostasis	186
cytochrome c release	219
gene polymorphisms	275
case group	186
pik3ca mutation	155
provide insights	126
whole exome sequencing	418
tumour progression	359
growth rate	214
several tumors	171
mir level	105
renal cell cancer	176
late stage	208
lower concentrations	136
fatty acids	250
inhibited apoptosis	134
hepatic resection	110
melanoma cell lines	192
apoptotic effects	348
complex network	104
one year	370
statistically different	183
immunohistochemistry showed	116
balb/c nude mice	115
nf Œ∫b signaling	298
ki67 expression	168
total thyroidectomy	225
multicenter study	199
every weeks	234
dose escalation	213
kras status	112
treatment initiation	151
advanced age	144
gene expressions	143
strongly expressed	193
rare form	132
higher rate	383
unfavorable prognosis	351
post transcriptional level	187
functional analysis	327
base excision repair	127
aml cell lines	136
deeper understanding	160
kaplan meier	316
mek inhibitors	364
single agents	207
novel therapeutic strategies	249
months confidence interval	268
genetic heterogeneity	150
familial adenomatous polyposis	196
drug delivery	240
braf v600e mutation	453
untranslated region utr	153
tnbc cells	459
poor disease free survival	107
distant organs	114
findings establish	111
chemotherapy resistance	433
alkylating agents	116
aurora kinases	105
anaplastic thyroid carcinoma	118
remaining patients	240
quantified using	100
actin cytoskeleton	288
studies indicate	144
colorectal cancer cells	905
different tissues	136
gallbladder carcinoma	115
patient characteristics	329
tp53 gene	192
human embryonic stem cells	142
psychiatric disorders	108
human neuroblastoma cells	135
e3 ubiquitin ligase	149
stable expression	114
single dose	268
immunodeficient mice	176
potential treatment	157
lymphatic invasion	291
il gene	122
highest levels	126
mir 133b	153
apoptosis assays	146
rate limiting enzyme	147
predict survival	151
effective therapy	306
directly associated	125
venous invasion	141
estrogen receptor positive breast cancer	121
constitutive activation	418
various cancer cell lines	122
propidium iodide	148
various concentrations	314
potential marker	249
present study evaluated	147
survival analyses	188
several lines	119
disease relapse	191
positive margins	120
long term results	101
rare disease	309
surgical outcomes	149
hospital stay	322
urokinase type plasminogen activator	100
sphere formation	199
carcinoma cells	210
leukemia cell lines	117
long term use	105
overall survival time	140
standard therapies	107
serious adverse events	210
effective approach	166
high risk patients	430
low risk patients	114
tight junctions	115
cervical lesions	125
western blots	197
high grade	585
originally identified	146
cellular migration	121
direct inhibition	106
dramatic increase	100
formalin fixed paraffin embedded	216
mir 5p expression	160
patients aged years	255
tnm stages	110
estrogen receptor positive	321
potential utility	234
large amount	146
peritoneal cavity	129
anticancer therapies	121
growth factor	148
analysis revealed	280
biochemical recurrence	590
primary outcomes	144
one study	126
c index	236
external validation	121
xenograft models	299
therapeutic outcome	109
clinical records	108
predictive accuracy	160
total patients	102
aberrantly expressed	362
tumor samples	721
basal like breast cancer	135
current therapies	176
b nhl	130
bone marrow involvement	113
type ii	153
natural products	254
pathological data	125
hormone receptor status	228
vegf c	491
concurrent chemoradiotherapy	161
complete response	802
gene expression analysis	247
induces cell cycle arrest	105
visual acuity	101
stage iv	304
gross total resection	136
world health organization classification	108
low grade glioma	133
total dose	106
results treatment	174
primary surgery	128
maintenance treatment	106
case suggests	103
antiangiogenic therapy	152
new paradigm	122
b cell	146
rare variant	166
uterine leiomyoma	143
preoperative diagnosis	194
somatostatin analogues	109
varying degrees	136
cytotoxic chemotherapy	235
common form	262
k ras	241
new treatment strategies	111
treating patients	275
patients operated	105
high recurrence rate	123
infectious diseases	261
dlbcl patients	212
three cell lines	178
higher percentage	206
pleomorphic adenoma	133
exome sequencing	188
parental cells	352
pancreatic cancer patients	284
anaplastic thyroid cancer	134
cases reported	141
gene encoding	178
intestinal epithelial cells	149
comprehensive review	222
physiological role	127
crc development	112
cellular metabolism	239
reported cases	195
might serve	167
tumor suppressor role	164
pulmonary metastases	114
three months	176
pituitary adenoma	235
residual tumor	199
inactivating mutations	119
molecular studies	156
adverse reactions	150
human hepatocellular carcinoma cells	166
e cad	140
bel cells	105
invasive carcinoma	190
using immunohistochemistry	269
multivariate analyses revealed	113
human leukocyte antigen	203
single center experience	136
histological diagnosis	187
randomized trials	148
positive breast cancer	241
real time quantitative polymerase chain reaction	203
also inhibited	228
synovial sarcoma	213
underlying molecular mechanism	339
pro apoptotic effect	102
eoc cells	202
strong evidence	100
hep cells	182
renin angiotensin system	131
therefore investigated	103
wild type egfr	187
pooled hr	137
mcf breast cancer cells	336
acquired drug resistance	140
data demonstrated	435
stem cell markers	226
sentinel lymph node biopsy	205
postoperative course	116
laboratory findings	119
supportive care	100
long noncoding rna	214
messenger rna	391
year follow	464
cancer related deaths	325
prominent role	168
yes associated protein	227
cancer metabolism	113
cytokine release	104
increased risks	115
likely due	268
ny eso	128
multiple myeloma patients	134
clinical remission	131
kaplan meier analysis showed	155
tumor number	116
co cultured	398
minor allele	133
gg genotype	378
aa genotype	321
significant impact	421
mgmt promoter methylation	162
genomic alterations	262
improve outcomes	229
ovarian tumors	211
pooled sensitivity	166
late stages	171
radical surgery	247
commonly found	124
novel mutation	151
published literature	147
human colon cancer cells	265
gg vs	113
anti cancer drugs	246
circulating mirnas	127
highly upregulated	104
socioeconomic status	114
age range	212
finding suggests	133
non small cell lung cancer patients	276
adjusted odds ratio	214
negative expression	186
protective factor	140
dietary intake	106
hospital based case control study	124
95%ci p	106
increased cell proliferation	129
novel regulator	222
tnf inhibitors	252
relevant studies	206
anti tumor immunity	106
results confirm	176
unfolded protein response	341
il production	318
parotid gland	145
remains unknown	303
human colon cancer	134
isocitrate dehydrogenase	366
grade ii	315
idh mutation	107
exact mechanism	159
vs p	104
human colorectal cancer cells	255
currently unknown	146
prognostic indicator	233
mek inhibition	183
acute myeloid leukaemia	295
dna sequencing	284
chromosomal aberrations	115
odds ratio confidence interval	117
hospital mortality	109
heart rate	154
osteogenic differentiation	226
normal subjects	151
structural features	102
akt/mtor pathway	111
potential effect	143
clinical variables	299
large scale	117
underwent radical prostatectomy	126
dna extracted	117
discovery cohort	136
two snps	145
copy number	247
mainly expressed	145
primary cultures	182
cytokine signaling	190
solid tumor	194
patients receiving	162
potential molecular target	139
integrative analysis	156
several cancer types	194
promoting apoptosis	169
binding sites	251
gbm patients	337
surgical intervention	166
cells compared	169
large series	222
chronic lymphocytic leukaemia	224
also discuss	280
signalling pathways	143
findings provide evidence	169
g1 phase	613
proliferation inhibition	126
downstream genes	106
akt pathway	276
placebo controlled trial	164
radiographic progression	100
previously treated	128
human gastric cancer	356
gc cell lines	211
mir 199a 3p	117
functional target	125
increased activity	133
fully characterized	126
platelet derived growth factor	159
prolong survival	114
negative effects	114
low concentration	152
relevant literature	128
histological examination	233
tuberous sclerosis complex	537
structural basis	219
pet ct	160
review article	177
remain unclear	223
precise role	173
molecular mechanism underlying	221
migration ability	286
potent inhibitor	383
predominantly expressed	136
mapk signaling	129
independent prognostic indicator	225
proteomic analysis	209
december patients	147
stratified analysis	201
arm b	224
future clinical trials	156
clinically relevant	162
mammary epithelial cells	115
radiation resistance	102
current research	102
hcc cases	113
intestinal type	102
ovarian function	100
novel method	202
adjuvant setting	215
human hepatoma cells	159
histologic grade	255
breast cancer subtype	119
univariate analysis revealed	101
aa vs	110
proliferating cells	123
cell counting kit	394
c fos	210
white blood cells	158
local invasion	138
nf Œ∫b signaling pathway	246
gastric cancer tissues	535
tumor diameter	217
western blotting showed	139
predictive model	115
could benefit	114
liver function	191
either group	129
fusion gene	129
routine practice	112
final diagnosis	350
telomerase reverse transcriptase	197
tert promoter mutations	295
tert promoter	135
schwann cells	121
eight cases	133
review aims	236
mir 26a	266
human bladder cancer cells	109
drug sensitivity	269
physical examination	248
laboratory parameters	108
good prognosis	414
adverse prognosis	157
fallopian tube	206
histological subtype	198
clear cell carcinoma	153
malignant ascites	100
sigmoid colon	101
cell activity	143
cell receptor	381
bcr abl	293
predicts poor prognosis	132
neck region	191
exogenous expression	170
malignant lymphoma	159
l asparaginase	211
low concentrations	264
brca2 mutation carriers	203
angiotensin ii	154
whereas patients	137
inflammatory processes	183
nuclear grade	120
virtual screening	185
high number	185
co delivery	179
either agent alone	126
targeted sequencing	171
durable response	100
primary resistance	118
study cohort	133
findings revealed	237
slightly higher	101
cancer cases	119
allo hsct	283
acute myeloid leukemia patients	107
first months	157
investigation revealed	116
pdac cells	293
second line therapy	314
integral part	113
well defined	348
high grade dysplasia	183
total testosterone	142
atrial fibrillation	107
venous thromboembolism	283
adjuvant trastuzumab	107
clinical findings	180
histopathological diagnosis	169
entire cohort	288
cisplatin based chemotherapy	154
study found	194
background colorectal cancer	180
colon cancers	166
kras mutation status	131
pathological response	168
leukemic cells	421
tumor infiltrating lymphocytes	659
unique case	151
patient underwent	174
medical therapy	128
positive expression rate	198
preoperative chemotherapy	137
high expression level	147
group c	313
long noncoding rnas	482
clinical implication	149
hbv infection	244
operative time	133
multiple studies	115
untreated cells	221
cca cells	131
significantly differ	149
pcos group	157
anti apoptotic proteins	160
stat3 phosphorylation	101
observational studies	214
intervention group	143
identified proteins	121
drug metabolism	104
three years	121
urothelial carcinoma	558
alk inhibitors	195
pathologic features	183
ecog ps	103
hepatic steatosis	157
eosin staining	112
neoadjuvant treatment	250
endometrioid adenocarcinoma	111
endometrial carcinomas	122
significantly less	101
vitro fertilization	162
cervical cancers	133
rare cases	133
p whereas	143
induced expression	123
reduced overall survival	141
results mir	129
relative expression	291
total rna	233
benign lesions	238
novel series	143
hiv infected patients	158
cd4 count	108
functional consequences	210
peripheral neuropathy	111
compared using	196
high throughput screening	171
fatty acid synthase	213
lung carcinoma	155
childhood cancer	133
acute myeloid leukemia cells	103
decreased phosphorylation	103
simultaneous inhibition	108
cox proportional hazards models	167
chronic phase	163
tyrosine phosphorylation	116
pca progression	116
main aim	112
may lead	483
neuroprotective effect	114
neuronal cells	154
significantly affected	149
western blot analysis indicated	101
advanced cancer	291
stratify patients	141
large panel	105
transcriptional repressor	126
cytotoxic drugs	153
septic shock	171
oncogenic potential	177
bone marrow samples	126
mds patients	164
multivariate analysis demonstrated	138
histological types	137
long term exposure	126
aberrant methylation	184
tumor xenografts	193
disease status	157
treatment modalities	211
glioma patients	598
osteosarcoma cell lines	167
examine whether	117
significant change	306
escc tissues	263
small non coding rnas	234
mir expression levels	154
result showed	143
therapeutic agent	280
young children	133
cell free dna	131
brief review	121
neuron specific enolase	253
immune checkpoints	180
individual patient	105
brca2 genes	106
p erk1/2	196
longer survival	177
conventional therapy	139
er positive breast cancer	164
functional outcomes	142
evaluable patients	214
different effects	107
immunohistochemical method	103
parp inhibition	162
breast cancer samples	148
potential value	246
recent evidence	162
metabolic reprogramming	261
polo like kinase	209
population based study	228
cell exhaustion	120
insulin like growth factor binding protein	130
erk signaling	112
situ hybridisation	157
patient derived xenografts	177
definitive diagnosis	182
pi3k/akt/mtor signaling pathway	149
anti egfr	104
included patients	385
response evaluation criteria	249
neuroendocrine carcinoma	123
granulosa cells	217
healthy control group	157
therapeutic purposes	133
psa density	118
pediatric patients	556
abundantly expressed	137
patients older	116
akt signaling pathway	136
promote proliferation	118
neck cancer patients	136
cell populations	175
primary care	111
study protocol	106
health related quality	211
stable overexpression	126
p53 overexpression	117
mir levels	248
median vs	123
comprehensive analysis	296
tp53 mutation	256
molecular heterogeneity	121
present case	185
vitamin e	131
important therapeutic target	132
vs months	161
smoking history	301
liver cells	117
women worldwide	270
new therapeutic strategies	218
mtor inhibition	167
clinical testing	125
curative resection	325
prognostic values	324
methods women	120
affected patients	129
chemokine receptors	101
angiogenic factors	187
histologic subtype	126
widely expressed	219
novel biomarker	489
cancer pathogenesis	142
copy number variations	169
copy number alterations	219
lung adenocarcinoma cells	232
effective therapeutic strategy	128
secondary end points	126
functional assessment	101
common adverse events	172
cell subsets	282
pro inflammatory	163
salivary gland tumors	105
essential component	152
scc cells	145
immune escape	180
kidney disease	109
retrospectively studied	104
anti vegf	108
acute kidney injury	187
renal cancer	280
statistical tests	200
two sided	206
significantly shorter	330
cancer recurrence	241
results based	140
distant sites	100
opposite effect	287
relatively rare	112
myocardial infarction	249
prognostic importance	125
retrospectively evaluated	235
human immunodeficiency virus	274
major problem	150
cml cells	173
poorly defined	137
connective tissue growth factor	104
longer overall survival	186
oncogenic roles	101
tumor sites	128
urinary bladder	294
differentiated thyroid carcinoma	126
endothelial function	111
body composition	381
p53 activation	104
tumor associated macrophages	540
significant upregulation	147
novel therapeutics	167
peritoneal carcinomatosis	118
peritoneal dissemination	183
various solid tumors	109
epithelial cancers	100
gbm cells	521
macrophage infiltration	112
hormone receptor positive breast cancer	147
breast cancer recurrence	129
distant recurrence	182
myeloid cell leukemia	107
cyclin dependent kinases	231
induced cell cycle arrest	266
bax expression	117
hct cells	240
hippo pathway	405
gonadotropin releasing hormone	189
environmental factors	364
oncogenic transformation	160
immunohistochemical analyses	216
control mice	162
neoadjuvant chemoradiotherapy	183
long term prognosis	110
systemic mastocytosis	133
multiple mechanisms	176
kidney transplantation	164
positive correlations	119
er stress	542
incidence rates	164
person years	139
phase trial	340
chemotherapy regimens	131
eastern cooperative oncology group	115
white blood cell count	154
received treatment	108
common grade	100
phosphorylation status	125
kinase domain	178
neuropathic pain	153
triple negative breast cancer cells	226
female ratio	138
particular interest	180
clinical benefit rate	105
dose reduction	144
regenerative medicine	171
recent research	142
side effect	101
target protein	112
study subjects	100
chromatin remodeling	164
postoperative recurrence	113
crc cell lines	306
age group	236
various biological processes	110
ca ix	182
allergic rhinitis	114
recent studies suggest	213
antibody drug conjugates	186
bladder cancer patients	174
eoc tissues	103
mir might	116
present evidence	144
pediatric acute lymphoblastic leukemia	109
otherwise specified	324
poor performance status	143
negative regulation	299
common malignant tumor	124
anti inflammatory cytokines	208
third leading cause	207
nuclear receptors	147
surgical excision	220
hcc treatment	160
kidney cancer	290
kaplan meier survival analysis	204
sox2 expression	117
alternative splicing	389
anti tnf therapy	338
cohort study	249
cd patients	144
small bowel	116
eleven patients	113
common event	108
sample size	194
metastatic pancreatic cancer	103
circulating cell free dna	102
cushing's disease	151
pituitary gland	131
five years	163
serum prostate specific antigen	164
mean time	140
promising results	179
cell functions	103
right side	110
intravenous injection	140
genetic landscape	101
hub genes	146
histological subtypes	162
present work	395
myometrial invasion	118
coronary heart disease	143
marked reduction	157
post hoc analysis	106
much lower	155
preoperative chemoradiotherapy	115
oncological outcomes	133
median number	291
tumor necrosis factor interleukin	102
structure activity relationship	196
ht29 cells	196
localized prostate cancer	341
cytoreductive surgery	134
well described	179
hyperthermic intraperitoneal chemotherapy	106
initial surgery	117
nb cells	133
function studies	100
evidence indicates	100
major depressive disorder	152
positive feedback loop	218
clonal expansion	130
radical cystectomy	209
international society	120
bipolar disorder	164
hematopoietic stem cell transplantation	247
candidate genes	335
shorter os	223
colorectal adenomas	120
validation set	275
common subtype	114
shown efficacy	116
baseline levels	124
immune activation	126
common causes	182
ccrcc cells	104
common types	182
significant relationship	331
invasion depth	127
case reports	239
hla dr	263
good agreement	100
nonsmall cell lung cancer	241
analyzed patients	107
n terminus	216
extracellular domain	269
non hodgkin's lymphoma	312
year old male patient	204
proteasome inhibitors	204
renal dysfunction	101
fibroblast growth factor receptor	267
neuroendocrine differentiation	218
specific inhibition	133
clonogenic survival	128
18)f fdg	111
different grades	150
present study investigated	571
normal levels	138
exosomes derived	123
gene polymorphism	108
caucasian patients	109
intrinsic pathway	121
systematic literature search	137
fold increased risk	151
tumour tissues	140
markedly upregulated	148
anti proliferative activity	164
sh sy5y cells	357
disease development	142
non steroidal anti inflammatory drugs	111
appropriate treatment	134
also considered	106
bone morphogenetic protein	201
grade neutropenia	122
year old woman presented	244
little effect	199
renal failure	172
analyzed data	101
annexin v binding	120
eukaryotic cells	154
multiple malignancies	105
neuroendocrine tumor	113
human ovarian cancer cells	198
mir mimics	273
wild type mice	239
human hcc tissues	101
brafv600e mutation	114
year old patient	226
larger tumors	126
primary endpoints	145
underwent surgical resection	178
tumor staging	104
control patients	189
neural stem cells	103
glioma stem cells	180
cisplatin sensitivity	147
performed whole exome sequencing	133
mir functions	206
pulmonary metastasis	156
tissue specimens	171
malignant phenotypes	158
pca tissues	155
cancer prognosis	141
reduced cell proliferation	105
g1/s transition	109
ongoing clinical trials	162
pd 1/pd l1	143
months months	104
postoperative radiotherapy	145
clinical decision making	149
a2780 cells	134
docosahexaenoic acid	141
cellular apoptosis	139
emergency department	149
apoptotic activity	132
n acetylcysteine	150
annexin a1	104
n patients	128
myeloid neoplasms	127
missense mutations	181
increased frequency	167
serum cea	109
lung function	111
experimental study	126
normal breast tissues	137
osteosarcoma patients	327
target therapy	112
least months	185
lipid droplets	116
nutritional status	231
conventional treatment	117
data collection	103
mucoepidermoid carcinoma	113
inflammatory bowel diseases	217
lymphocyte antigen	186
hippo signaling pathway	146
cancer survivors	170
prostate tumors	142
currently available	197
may help	214
pooled hazard ratios	119
medical sciences	113
biochemical parameters	161
pap smear	126
peroxisome proliferator activated receptor gamma	106
major mechanism	109
host cells	164
durable responses	126
clinical experience	141
gene expression changes	103
key event	103
different cancer types	147
significant decreases	102
high risk disease	133
expression analysis	196
gene expression omnibus database	209
differentially expressed mirnas	236
mainly involved	108
drug combination	102
subgroup analysis showed	108
early development	114
wst assay	101
mtor inhibitor	220
her2 positive tumors	106
treatment discontinuation	110
h ras	103
npc cell lines	113
vivo experiments	240
suppressive effects	192
group ii	241
group iii	124
promotes cell proliferation	148
surface plasmon resonance	124
deleterious effects	135
great interest	229
aggressive prostate cancer	128
lung adenocarcinomas	340
alk rearrangement	226
fully investigated	115
hcc recurrence	206
functional assays	194
multiparametric magnetic resonance imaging	108
rare tumors	141
von willebrand factor	118
patient care	102
ovarian endometriosis	106
partial nephrectomy	151
positive surgical margins	147
tumor infiltrating	126
incurable disease	100
case study	180
least partially	186
personalized therapy	119
different cell types	136
egfr expression	338
clonogenic assays	101
wound healing assays	188
less sensitive	131
reach statistical significance	158
laryngeal squamous cell carcinoma	352
adhesion molecules	208
key player	230
identify genes	129
molecular pathways	201
target effects	155
vivo model	159
combined inhibition	189
benign disease	109
dismal prognosis	282
cancer biomarkers	134
malignant tumours	113
year history	131
roux en	110
mechanistic target	254
central regulator	120
npc patients	330
key step	125
adaptive immune response	112
prognostic markers	495
platelet derived growth factor receptor	167
drinking water	118
cigarette smoke	197
treatment decisions	139
different cancers	315
present study reports	125
anti angiogenic therapy	157
bc risk	164
u2os cells	198
chemotherapy drugs	174
antiretroviral therapy	182
additive effect	124
co localization	158
vitro cytotoxicity	176
functional activity	111
ascorbic acid	104
liquid chromatography tandem mass spectrometry	122
cohort studies	108
many years	193
statistically significant correlation	182
near infrared	105
periodontal disease	105
cancer related fatigue	124
consecutive series	116
non small cell lung carcinoma	358
newly diagnosed patients	177
cancer death	343
insulin receptor	144
initially diagnosed	100
trail induced apoptosis	245
molecular testing	270
reliable method	103
surgical procedure	128
decision making	178
serum mir	164
control samples	205
primary cause	143
human cervical cancer cells	135
autophagy induction	148
t790m mutation	201
jak2 v617f mutation	132
haematological malignancies	137
mean duration	130
dna repair genes	207
synthetic lethality	126
combination group	129
used alone	118
follicular fluid	108
evaluate whether	203
histopathologic features	122
lung adenocarcinoma patients	252
case presentation	107
mir 27a	192
kaposi's sarcoma	126
bc cells	217
clinical progression	120
adjacent non tumor tissues	261
paraffin embedded tissues	118
cancer type	264
oral leukoplakia	139
results one hundred	126
egfr tyrosine kinase inhibitor	118
confounding factors	102
three snps	110
half maximal inhibitory concentration	171
untreated patients	145
european ancestry	112
autophagic cell death	123
day cycles	112
ln metastasis	132
extracted data	114
patient cohort	117
pediatric population	146
stratified analyses	108
copd patients	177
human osteosarcoma cells	219
adc values	122
clinicopathologic variables	120
increasingly recognized	179
nerve growth factor	120
postoperative chemotherapy	101
uterine leiomyomas	183
molecular pathogenesis	366
serum biomarkers	132
mir 181a	192
experimental model	144
therapeutic value	159
acute phase	111
many kinds	131
mir 19a	165
bladder cancer tissues	132
recruited patients	109
functional importance	101
g2 phase	115
surface expression	144
mitotic catastrophe	110
despite recent advances	109
aurora kinase	189
wilms tumor	161
pathogenic mutations	110
model system	187
single center	271
postoperative day	158
cellular function	118
experimental data	153
data suggests	220
synthesized compounds	134
mitochondrial dna	116
anti apoptotic	111
signaling molecules	145
nf Œ∫b p65	207
new compounds	135
two polymorphisms	119
longer os	147
gelatin zymography	110
combined effect	181
prospectively collected	115
gene ontology	407
bcl bax	144
psa levels	218
thyroid cancers	136
present study revealed	301
critical step	129
intratumor heterogeneity	101
important mediators	105
hcc progression	271
ubiquitously expressed	114
recent progress	216
flow cytometry assay	118
sgc7901 cells	139
identified using	211
mrna expression level	128
diagnostic tool	125
frequently downregulated	158
migration abilities	112
normal breast tissue	143
mcf 7/adr cells	159
erk pathway	164
lung cancer treatment	174
e selectin	139
direct target gene	240
new therapeutic strategy	123
proliferation ability	117
sensitive detection	161
cervical squamous cell carcinoma	166
cell lines compared	173
g2/m phase arrest	106
precision medicine	365
advanced cancers	104
gene silencing	265
apoptosis resistance	120
raji cells	104
theoretical basis	106
tissue inhibitors	106
clinical examination	144
day mortality	184
blood loss	141
ibd patients	176
disease course	189
mgmt methylation	128
poor patient prognosis	128
still lacking	172
diagnostic challenge	126
prominent nucleoli	110
remaining cases	118
brentuximab vedotin	210
chronic hbv infection	154
methods participants	100
amyotrophic lateral sclerosis	176
rna binding protein	120
mutational landscape	117
nucleic acids	131
multidrug resistance protein	110
different doses	190
paclitaxel treatment	103
high risk human papillomavirus	170
prostate volume	239
psa level	277
immunohistochemical characteristics	107
also measured	240
ec patients	156
diabetic patients	261
hedgehog signaling	130
primary cilia	114
proliferative capacity	103
marked decrease	147
interleukin receptor	102
h460 cells	149
uterine fibroids	156
immune microenvironment	109
pathological parameters	119
bariatric surgery	129
novel therapeutic approach	231
a549 lung cancer cells	155
hepatocellular cancer	131
histologic type	136
findings identify	101
month period	120
male gender	192
er expression	153
diffusion weighted imaging	148
added value	101
activated b cells	143
least one dose	121
fold increase	446
extensively investigated	160
markedly higher	157
inhibited tumor growth	106
thymic stromal lymphopoietin	139
tnm staging system	100
risk factors associated	115
metastatic rcc	128
accumulating evidence suggests	179
chemotherapy response	178
trastuzumab emtansine	132
cancer treatments	142
fertility preservation	114
deadly disease	130
restriction fragment length polymorphism	113
mechanisms responsible	175
post translational modification	124
recent decades	156
thyroid stimulating hormone	108
stromal cell derived factor	100
platinum resistance	121
diffuse large b cell lymphomas	106
transcript levels	137
markedly downregulated	104
mir 20a	199
metabolic stress	120
provided evidence	151
directly regulated	109
mir 27b	100
healthy cells	108
protein protein interaction	291
annexin v staining	103
important prognostic factor	160
mir 106a	126
worse outcome	212
cd133 expression	182
intensive care unit	127
cell population	189
self renewal capacity	124
oscc tissues	142
chronic hepatitis b	255
hdl c	193
luciferase activity	181
diagnostic criteria	230
good response	194
p53 gene	168
oncogenic function	148
ara c	142
immunohistochemical markers	167
survival analysis showed	115
human cell lines	120
pathological characteristics	258
logistic regression model	131
tgf induced emt	155
mir 320a	116
transmembrane protein	105
adjacent noncancerous tissues	150
catenin expression	178
poly adp ribose polymerase	141
breast cancer cell line	100
clin cancer res	351
regulatory effect	134
complete loss	132
pleural fluid	113
present study indicate	117
integrated analysis	211
gastric bypass	101
sex hormones	139
psa testing	126
magnetic resonance	111
multiple types	260
lymphoma patients	100
hsp90 inhibitors	155
non alcoholic steatohepatitis	107
vivo imaging	140
worse outcomes	113
red blood cells	121
escc cell lines	129
breast cancer metastasis	311
colorectal tumors	209
potential markers	127
cancerous tissues	195
colorectal adenocarcinoma	200
myasthenia gravis	146
well differentiated	150
activated caspase	106
clinical history	102
leukemia inhibitory factor	147
tgf expression	103
gene expression levels	223
immunohistochemical evaluation	135
left breast	106
mitochondrial function	229
g protein coupled receptor	178
pt stage	117
colony formation assays	301
multiple testing	148
year progression free survival	137
kr√ºppel like factor	105
negative effect	124
overall response	106
braf inhibition	106
patients completed	109
invasive abilities	170
patients included	217
mitotic index	110
b7 h3	249
pre clinical	100
papillary carcinoma	102
immunohistochemical examination	100
csc markers	115
u87 cells	211
cell counting kit assay	154
therapy response	137
clinicopathological data	227
light microscopy	110
key genes	181
immunohistochemistry revealed	109
focally positive	130
valproic acid	161
metastatic gastric cancer	107
severe acute pancreatitis	113
currently used	193
aggressive type	127
widely studied	165
still elusive	122
potential drug target	117
ec cells	167
malignant tumor	232
mir inhibitor	212
present study aims	221
promising targets	131
paracancerous tissues	101
immunohistochemical detection	120
spontaneous regression	111
histopathological features	204
diffusely positive	127
peutz jeghers syndrome	105
nasal cavity	141
case illustrates	106
patients carrying	173
invasive breast carcinoma	100
helicobacter pylori infection	106
new cases	103
et al	135
vivo assays	114
x linked inhibitor	153
apoptosis protein	209
studies show	151
predicting prognosis	189
tested using	100
kaplan meier survival analysis showed	102
maximum standardized uptake value	133
tnm classification	233
vascular smooth muscle cells	101
significant downregulation	114
study describes	164
q pcr	105
anti tumor efficacy	102
akt inhibitor	121
inhibitory role	126
gastrointestinal stromal tumor	206
aerobic glycolysis	345
neurological disorders	169
increased proliferation	238
scoring system	122
chemotherapy regimen	114
placebo controlled	220
promising candidates	143
protein coding genes	116
genomic analysis	113
rare subtype	129
endoplasmic reticulum stress	263
cell phenotype	106
unfavorable outcome	102
prostate cancer screening	128
north america	134
adjuvant radiotherapy	213
epigallocatechin gallate	192
mtor signaling	203
protein translation	101
mir 181b	101
multiplex ligation dependent probe amplification	145
advanced tnm stage	305
enrolled patients	407
high mortality	286
fourth leading cause	104
diagnostic odds ratio	121
promote apoptosis	208
report describes	140
pro apoptotic	141
mir 130b	101
novel prognostic biomarker	196
h1299 cells	231
clinical aspects	107
anastomotic leakage	121
sh sy5y	150
results point	102
cell development	127
predictive power	122
endometrial cancer patients	104
chronic myelomonocytic leukemia	154
complex karyotype	126
reference group	101
tcga database	138
egfr inhibition	139
iranian population	145
considered statistically significant	120
non smokers	253
succinate dehydrogenase	115
proteins associated	135
poor patient survival	181
gene set enrichment analysis	171
united kingdom	100
blood transfusion	114
cardiovascular system	106
limited treatment options	178
negative regulators	164
high accuracy	125
obese subjects	109
key determinant	100
aromatase inhibitor	143
tissue damage	105
pro inflammatory mediators	108
higher prevalence	249
mg cells	246
cord blood	112
healthy control	116
significantly larger	105
larger tumor size	332
important roles	340
ppi network	207
ion channels	109
mir 196a	110
overcome drug resistance	136
mir 29b	230
diagnostic potential	102
phase study	355
philadelphia chromosome	110
low grade gliomas	170
inhibits proliferation	156
oropharyngeal cancer	116
high risk hpv	109
cox proportional hazard model	163
detailed mechanism	105
grade iv	110
still largely unknown	131
wnt pathway	262
various mechanisms	103
ldl c	237
il 17a	395
high dose	176
cell fate	130
anticancer potential	145
risk assessment	208
liver tumors	130
normal endometrium	135
hbv related hcc	182
pc patients	173
anti proliferative effect	217
human glioma	286
groups according	133
concordance index	110
cyclin d1 expression	177
also required	115
epidermal growth factor receptor tyrosine kinase inhibitors	189
ribosome biogenesis	117
mtt method	114
lymphoma cells	260
vegf levels	124
liver damage	100
nf kb	191
protein expression level	172
myeloproliferative neoplasm	115
mpn patients	104
potential effects	149
reviewed retrospectively	146
pulmonary arterial hypertension	104
severe side effects	106
identified cases	100
palliative care	133
novel inhibitor	118
total gastrectomy	103
stress conditions	115
mir 449a	113
mouse xenograft model	244
gene signature	155
cervical cancer screening	202
left ventricular ejection fraction	106
recently approved	154
multiple endocrine neoplasia type	172
breast conserving surgery	192
glucagon like peptide	112
least one	214
her2 positivity	128
routinely used	113
concomitant increase	103
ongoing trials	100
adverse event	104
early stage cervical cancer	135
tgf signaling pathway	147
metastatic non small cell lung cancer	160
urine samples	175
new type	108
univariate analysis showed	196
genomic landscape	168
cr rate	108
right eye	118
methods cases	115
dce mri	151
autophagic flux	144
neuronal differentiation	144
lower level	187
rat model	247
significant negative correlation	148
lung cancer progression	116
effective way	107
chemotherapeutic agent	176
molecular weight	126
ang ii	144
dna pk	126
free testosterone	114
synovial fluid	128
intercellular communication	104
control arm	127
special emphasis	162
inflammatory process	129
better outcomes	113
multivariate cox regression analyses	103
tumor subtype	115
examined whether	100
training set	311
methods cell viability	115
lower frequency	116
milan criteria	158
fully explored	105
functional relevance	144
results confirmed	127
18f fdg pet/ct	111
novel drugs	125
s√©zary syndrome	132
using flow cytometry	118
pathways involved	149
target proteins	185
mycn amplification	148
mitochondrial biogenesis	112
inkt cells	133
mg63 cells	125
human bladder cancer	128
also upregulated	127
three cycles	102
emt phenotype	140
locally advanced rectal cancer	264
papillary renal cell carcinoma	103
idh mutations	140
idh1 mutation	208
lipid rafts	167
south africa	122
tumor immunity	129
bcr abl1	112
function mutation	105
eml4 alk	111
nb4 cells	105
regulatory network	105
lymphocyte subsets	119
drug treatment	178
meta analysis suggested	112
primary liver cancer	112
sensitive marker	120
cisplatin induced apoptosis	135
cytogenetic abnormalities	109
study explored	141
beta catenin	206
non tumor tissues	152
malignant pleural effusion	198
programmed death ligand	446
cea levels	117
normoxic conditions	121
cathepsin k	104
cancer vaccines	101
multiple pathways	100
nras mutations	133
advanced hepatocellular carcinoma	256
cpg sites	137
metastasis formation	110
objective responses	104
treatment planning	112
cowden syndrome	137
novel tumor suppressor	132
young age	245
circulating tumor dna	206
node negative	113
mir 92a	162
lymph node dissection	163
treat population	138
inhibited proliferation	136
least partly	127
proteins related	105
single arm	185
frequent event	108
radiation dose	107
similar effects	154
binding mode	113
year os rates	136
marital status	100
common cancer worldwide	131
anti cancer therapy	162
increased rate	121
primary lung cancer	136
renal cancer cells	129
tumor node metastasis stage	125
rapid progression	137
last two decades	138
surgical removal	141
early mortality	104
nasal polyposis	117
potential functions	100
hodgkin's lymphoma	156
cancer specific	102
potential function	122
laboratory data	148
erŒ± expression	100
phase iii trial	120
systematically searched	109
thus providing	141
pathological type	105
mir 125b	363
training cohort	205
cox regression models	140
normal karyotype	163
biological features	142
work suggests	104
cdk4/6 inhibitors	123
promising agent	130
expression profiling	123
viral replication	152
human genome	222
kras gene	115
liver resection	206
upper tract urothelial carcinoma	126
two methods	111
endoscopic resection	104
clonogenic assay	146
atopic dermatitis	208
high fat diet	255
non carriers	164
early identification	119
upper limit	121
larger cohort	143
biological agents	105
infectious complications	117
inflammatory disorders	115
serum alpha fetoprotein	107
provide new insights	118
recurrent glioblastoma	180
cell receptors	136
anti cancer properties	110
significant risk factor	146
methods clinical data	119
hypoxia inducible factors	129
detailed analysis	134
glioma risk	107
left eye	116
aza deoxycytidine	149
logistic regression models	115
glucose homeostasis	115
bile acids	112
mir 106b	161
age matched controls	153
including gastric cancer	104
precancerous lesions	192
inhibiting cell proliferation	126
mir 15a	164
high selectivity	102
cirrhotic patients	160
nvp bez235	107
emerging roles	127
correlated significantly	101
special issue entitled	130
low density lipoprotein cholesterol	149
important tool	115
oc cells	133
paclitaxel resistance	122
months vs	131
quantitative assessment	127
anti mir	104
host immune response	109
survival advantage	163
breast cancer survivors	164
renal fibrosis	104
normal fibroblasts	113
advanced ovarian cancer	127
parathyroid carcinoma	117
oncogenic drivers	108
diagnostic biomarker	129
comprehensive overview	107
reverse transcription quantitative polymerase chain reaction	488
anti tnf treatment	124
inflammatory disease	105
worse survival	308
c terminal domain	128
salvage therapy	128
p vs	105
mir plays	134
nt probnp	108
last follow	300
tumor necrosis	146
anal cancer	114
nasal type	125
de novo	157
von hippel lindau disease	120
non homologous end joining	128
thyroid carcinomas	101
directly involved	106
rna immunoprecipitation	111
intravenous administration	129
expression changes	136
recurrent ovarian cancer	103
thymic carcinoma	112
tissue expression	106
hsa mir 5p	136
radical hysterectomy	129
positive surgical margin	109
curative surgery	144
physical interaction	111
vascular endothelial cells	205
ptcl nos	109
great britain	138
microrna 5p	110
mir 29c	127
several tumor types	114
science databases	103
laryngeal carcinoma	203
closely linked	160
long non coding rna	338
multi drug resistance	105
chronic rhinosinusitis	124
chemotherapy group	103
tumor suppressive role	192
pathways associated	100
systematic literature review	102
normal brain tissues	182
p16 positive	107
early gastric cancer	183
allo sct	101
treating cancer	129
exploratory analysis	111
serum amyloid	104
p16 status	112
preclinical evaluation	116
lysophosphatidic acid	106
intratumoral heterogeneity	137
high risk prostate cancer	149
chronic pain	102
patients aged	124
waldenstr√∂m macroglobulinemia	108
mir 23a	117
repeat biopsy	111
plasma level	104
dimer levels	110
brain cancer	112
increased cell apoptosis	105
propensity score matching	146
nasal polyps	117
high risk neuroblastoma	117
low quality evidence	110
main results	110
tumor budding	112
m2 macrophages	220
unassigned patients	166
gep nets	100
network meta analysis	108
deb tace	119
rights reserved	152
positive expression rates	108
renal carcinoma	101
cancer cachexia	177
alternative lengthening	121
mir 135b	118
myoepithelial cells	114
mir 125a 5p	112
prognosis prediction	111
hr 95%ci	152
molecular function	104
let 7a	204
background despite	102
let 7b	123
mir 23b	118
differentiated cells	130
gut microbiota	160
competing endogenous rna	171
anti ctla	103
programmed cell death protein	175
copyright pathological society	101
john wiley sons	123
u87mg cells	150
anti pd therapy	100
pd blockade	147
intensive chemotherapy	105
single cell level	124
mir 30a	154
mean difference	117
oral lichen planus	101
t47d cells	124
bax/bcl ratio	115
hcc cell proliferation	110
cancer genome atlas database	106
human keratinocytes	139
sorafenib treatment	118
patient stratification	106
es cells	110
expert opinion	273
p21 expression	137
nc group	117
c flip	133
checkpoint inhibitors	353
liquid biopsy	196
oesophageal adenocarcinoma	113
national cancer database	129
diffuse gliomas	112
reverse transcription‚Äëquantitative polymerase chain reaction	244
wiley periodicals	906
droplet digital pcr	122
circular rnas	112
mir 26b	136
identify predictors	157
mir mimic	202
copyright john wiley sons	128
immune related adverse events	121
article doi	145
cancer american cancer society	215
mol cancer ther	165
expert commentary	174
